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ABSTRACT

Exploring the Unique Characteristics of Cancer in Adolescents and Young Adults in Tennessee

by

Megan Quinn

Adolescents and Young Adults (AYAs) ages 15-39 years with cancer have received little
attention in the medical and health fields, resulting in a lack of progress for this age group. Little
is known about the unique biologic, epidemiologic, and psychosocial issues that play an integral
role in the AYA cancer journey. The purposes of this study were to use the Tennessee Cancer
Registry for all new cancer cases from 2004-2008 to determine 1) the main types of cancer that
affect AYAs in TN, 2) the predictors of late-stage diagnosis of melanoma, and 3) the factors that
predict a total thyroidectomy for cancer treatment. A total of 8,097 cancer cases were diagnosed
in AYAs in Tennessee from 2004-2008. The five main cancer types were breast cancers,
melanomas, thyroid cancers, lymphomas, and testicular cancers and accounted for over 50%
(N=4,269) of cancers in AYAs in Tennessee during the study period. Females were significantly
more likely to be diagnosed with melanomas (age adjusted incidence rate (AIR) 14.01, 95% CI
12.96-15.06) and thyroid cancers (AIR 13.39, CI 12.37-14.42) compared to males (AIR 8.08, CI
7.28-8.88 and AIR 3.50, CI 2.98-4.03, respectively). All cancer types increased with age.
Individuals with government insurance (OR 8.41, CI 3.04-23.27) and those 15-19 years of age
(OR 6.30, CI 1.74-22.86) had the highest risk of late-stage melanoma. Significant predictors of a
using total thyroidectomy for thyroid cancer treatment included regional/distant stage cancer at
2

diagnosis (OR 2.80, CI 1.34-5.85) compared to localized stage, papillary carcinoma (OR 2.64, CI
1.02-6.83) and papillary adenocarcinoma (OR 3.56, CI1.37-9.19) histology types compared to
follicular adenocarcinoma, and residence in non-Appalachian Tennessee (OR 2.07, CI 1.26-3.42)
compared to Appalachian TN. An increased awareness of cancer types that affect AYAs in
Tennessee will provide a basis for developing public health campaigns for cancer prevention and
control in this population. This research serves as a first step in using state-based cancer
registries to identify the unique characteristics of cancer in AYAs and will set the stage for future
state-based research in this underserved population.
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CHAPTER 1
INTRODUCTION
Immense progress has been made in the fields of cancer research, care, survival, and
awareness; however, there are still underserved populations. Over the past few decades
adolescents and young adults (AYAs), defined as those developing cancer between the ages of
15 and 39, have experienced an increased cancer incidence rate from 137.6 new cases per
100,000 in 1975 to 156.1 new cases per 100,000 in 2008 (AYAOPRG, 2006, Bleyer, Budd, &
Montello, 2006; Surveillance, Epidemiology, and End Results, 2011a). More than 72,000 AYAs
are diagnosed every year with cancer in the United States (Hayes-Lattin, 2011). Additionally,
cancer is the leading cause of nonaccidental death in this age group and AYAs have experienced
little to no improvement in cancer survival rates when compared to both younger and older age
groups (AYAOPRG, 2006).
Little is known about this population and the biologic, epidemiologic, genetic,
psychosocial, and economic issues that play a key role in the incidence, mortality, and quality of
life of AYA patients (AYAOPRG, 2006; Wu et al.2005). However, research shows that cancer
in AYAs has distinct features, with the spectrum of malignant disease in this population being
much different than malignancies seen in other age groups (Bleyer, 2002). In addition, the
disruption of cancer during this part of the life stage provides patients with unique psychosocial,
medical, physical, and educational needs (Bleyer, 2002).
Statement of the Problem
Cancer is the second leading cause of death in America and the first leading cause of
death due to disease in AYAs (AYAOPRG, 2006; CDC Fast Stats, 2011). The National Cancer
Institute (NCI) estimated that in 2011 there were over one million new cancer cases and more
14

than 72, 000 of those cases were AYAs, accounting for approximately 6% of all cancers
diagnosed (AYAOPRG, 2006; Hayes- Lattin, 2011; NCI, 2011a). The five overall leading
causes of cancer incidence in the United States are prostate, female breast, lung, colorectal, and
melanoma (NCI, 2011a). In comparison, the leading cancers in AYAs are breast, lymphomas,
melanoma, thyroid, and male and female gonadal cancers (AYAOPRG, 2006; Bleyer et al.,
2008). However, actual cancer incidence in AYAs varies greatly by age, gender, ethnicity, and
geography.
The Tennessee Cancer Registry (TCR) estimates that in 2009 approximately 32,000
Tennesseans were diagnosed with cancer and another 13,000 died from this disease (Li, Li, &
Whiteside, 2010). Consistent with United States (US) data, cancer is also the second leading
cause of death in Tennessee (TN) (Li et al., 2010). Tennessee has not specifically studied cancer
incidence and mortality in the AYA population.
Until recently, AYAs were not seen as a distinct group with specific needs. However, the
Adolescent and Young Adult Oncology Progress Review Group (AYAOPRG) have made
specific recommendations regarding cancer care, research, and awareness for this population
(AYAOPRG, 2006). AYAs with cancer have been described as ‘at the edge of no-man’s land’
and ‘the orphans of cancer’ (Bleyer, 2011; Hollis & Morgan, 2001). They are identified as a
population that falls into a care gap between pediatric and adult health services (Hollis &
Morgan, 2001). Due to the distinctive nature of AYA cancer, specific prevention and control
strategies should be created to target this population (Wu et al., 2005). Further research needs to
be conducted to understand the dynamic needs of this population in order to provide adequate
care, interventions, and cancer awareness for AYAs (AYAOPRG, 2006). The purpose of this
study is to explore the unique characteristics of AYA cancer in TN. The results from this
15

research are intended to increase awareness of AYA cancer and to promote public health
interventions to reduce the AYA cancer burden.
Research Aims
Research Aim #1- To describe the characteristics of adolescents and young adults who developed
cancer in Tennessee during the years 2004-2008, inclusive.
Research Aim #2- To determine the major cancer types that affect adolescents and young adult in
Tennessee during the years 2004-2008, inclusive.
Research Aim #3- To evaluate the predictors of late stage diagnosis of melanoma in adolescents
and young adults diagnosed in Tennessee during the years 2004-2008, inclusive.
Research Aim #4-To investigate the predictors of a total thyroidectomy as a surgery option in
adolescents and young adults diagnosed with thyroid cancer in Tennessee during the years 20042008, inclusive.
Tennessee
Tennessee is located in Central Appalachia and is a state that has distinct geographic and
demographic variations. It encompasses major metropolitan areas, suburban counties, and
several rural communities located in the Appalachian Mountains and the Mississippi Delta
region. Only 27 of TN’s 95 counties are considered urban and the other 68 are rural (Erwin,
Fitzhugh, Brown, Looney, & Forde, 2010). Overall, TN is comprised of roughly 80%
Caucasians and less than 20% African-Americans (Erwin et al., 2010). East TN has a relatively
homogenous Caucasian population, even in major urban areas like Knoxville (Erwin et al.,
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2010). Meanwhile, in West TN the percentage of African-Americans is proportionally higher
than the overall state percentage, with figures around 50% (Erwin et al., 2010).
Tennessee has the 22nd highest age-adjusted cancer incidence rate and the 5th highest
cancer mortality rate in the nation (Li et al., 2010). Roughly two thirds of cancers in TN could
be prevented through life-style changes, mainly through smoking cessation (Li et al., 2010). The
TCR Annual Report highlights that the majority of the counties that have high incidence and
mortality rates are located in the Appalachian region of TN (Li et al., 2010). This suggests that
Appalachian TN residents may be predisposed to developing cancer due to certain lifestyle
factors (Li et al., 2010). The TCR reports that for cancer in those less than 20 years of age, the
highest incidence rates are found in the 0-4 and 15-19 year old intervals. However, mortality
rates are relatively similar for all cancers that are diagnosed prior to age 20 (Li et al., 2010).
Currently in TN, AYAs are categorized into 1) children’s cancer (15-19 years old) or 2)
adult cancer (20-39 years old). To date, the cancer burden as it relates to AYAs has not been
investigated in TN. This research will provide an overview of AYA cancer incidence in TN and
provide a more in-depth analysis for two cancers frequently diagnosed in AYAs, melanoma and
thyroid cancer. Tennessee is a leader for aspects of cancer prevention and control through the
impact of the state-wide TN Cancer Coalition and the comprehensive cancer care provided by St.
Jude’s and Vanderbilt health systems. Developing a better understanding of overall cancer
incidence in the AYA population and identifying the predictors of late-stage melanoma and the
characteristics that predict total thyroidectomy as a cancer treatment will assist cancer
practitioners in TN to better serve this AYA population.

17

Definition of Adolescents and Young Adults
The definition of AYAs has evolved through the years and there have been many different
definitions based on age, psychosocial development, and societal influences (AYAOPRG, 2006).
Adolescence is a complex life stage and seen as a period of psychological and sociological
change as individuals progress from childhood dependence to an adult independent status over a
10-12 year period (Hollis & Morgan, 2001; Palmer, Mitchell, Thompson, & Sexton, 2007). It
has been observed that young adults face many of the same issues as adolescents (Li et al.,
2010).
Adolescence can be considered the continuum of development that occurs from the age of
13 to 23 years, but the exact age range may vary for any specific individual and depends on the
individual’s needs, circumstances, and development in the context of the requirements of society
(Hollis & Morgan, 2001). The variety of different age ranges given for adolescence reflects this
wide variation in the rate that individuals progress through adolescence. The World Health
Organization (WHO) defines young people as 10-24 years and further divides that into the
categories of 1) adolescence for ages 10-19 and, 2) youth for ages 15-24 (WHO, 1986). Society
commonly identifies adolescence as the age ranges that coincide with the teen years, ages 13
through 19. Adolescence predominately signifies the transition between childhood and
adulthood. This group is neither children nor yet fully adult, do not easily identify with one
definition and may be referred to as adolescents, teenagers, young people, or young adults,
interchangeably (Whiteson, 2003).
The Adolescent and Young Adult Oncology Progress Review Group (AYAOPRG, 2006)
opted to define the AYA population over a relatively wide age range in order to be inclusive of
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the entire spectrum of cancer patients that continue to experience a lack of improvement in
cancer care and survival (AYAOPRG, 2006). The current AYAOPRG and National Cancer
Institute (NCI) definition of AYAs includes individuals diagnosed with cancer between 15 and
39 years of age (AYAOPRG, 2006; NCI, 2012a). The AYAOPRG recognizes that this is not a
homogenous group and that developmental differences exist over this wide age range
(AYAOPRG, 2006). Although this age range is quite wide, individuals in this age group are
unified based on their unique differences in the cancer journey when compared to other age
groups (Wolfson, 2010).
Several distinct experiences in the AYA cancer journey are different from those
experienced by younger and older populations. These unique experiences include delays in
treatment, lack of clinical trials, and balancing treatment schedules with school, work, and young
families (LYSAA, 2006). Individuals in the 15-39 year age range are in the reproductive years,
so family planning and fertility preservation are both common themes for this population
(AYAOPRG, 2006). Individuals at the upper end of this age range have expressed that they
identify more with the younger patients than with middle-aged or older patients (AYAOPRG,
2006).
Prior to the AYAOPRG and NCI AYA definition, individuals in this broad age range
lacked a home in cancer care and research and were treated according to either pediatric or adult
protocols based on their specific cancer diagnosis (AYAOPRG, 2006; Albritton, 2005; Bleyer,
2005; Fernandez & Barr, 2006; LYSAA, 2006). The lack of a separate definition and placement
within cancer control and prevention has caused AYAs to be understudied and underserved; the
result has been a lack of overall progress for this age group (AYAOPRG, 2006; Albritton, 2005;
Bleyer, 2005; Burke, Albritton, & Marina, 2007; Fernandez & Barr, 2006; LYSAA, 2006). The
19

new formal definition of AYAs will help streamline research, interventions, treatment, and
awareness efforts in this population (AYAOPRG, 2006). Unless otherwise specified, the term
AYA as used for this study will be as defined according to AYAOPRG and NCI and will refer to
individuals in the 15-39 year old range, inclusive.
Cancer in Adolescents and Young Adults
AYA cancer patients have seen a lack of progress in cancer care and outcomes compared
to younger children and older adults (Bleyer, 2005). Cancer incidence among AYAs (ages 1530) in the United States accounts for about 2.0% of all cancers diagnosed, while cancer in
individuals under 15 only accounts for 0.8%; however, children’s cancers receive exponentially
more attention than do those in AYAs (Bleyer et al., 2006). In addition, the 5-year survival rate
for AYAs (ages 20-39) in the US has held constant at 70% since 1986 (Bleyer, 2005). Currently,
survival rates for AYAs 15-39 vary by cancer type. Of the most commonly diagnosed cancers in
AYAs (breast, Hodgkin’s lymphoma, thyroid, melanoma, and testicular), survival rates are 80%
and higher (Bleyer, 2011). However, acute myeloid leukemia, acute lymphoid leukemia, lung
carcinoma, and hepatic carcinoma have survival rates of less that 50% (Bleyer, 2011). Figure
1.1 illustrates the improvements in 5-year survival rates by age from the SEER Database, 19751997 (AYAOPRG, 2006).
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Figure 1.1. Improvements in 5-Year Cancer Survival Rates in the United States by Age
Source: AYAOPRG, 2006.
Figure 1.2 (AYAOPRG, 2006) illustrates the improvements in survival between 19751998 for AYAs, children, and older adults in the US. While AYAs have relatively high survival
rates, the lack of improvement over the time period, particularly in the 25-39 year age group is
concerning. In the 1970s and 1980s, AYAs had drastically higher survival rates than other age
groups; however, survival rates have stagnated in this population while they have improved in
younger children and older adults (AYAOPRG, 2006). It is not fully understood if the lack of
improvement in AYA survival rates stems from the biological differences that exist in AYA
cancer, from a lack of research, due to differences in treatment and health services, or due to
some other cause (AYAOPRG, 2006; LYSAA, 2006).
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Figure 1.2. Improvement in Cancer Survival in the United States by Age Group, 1975-1998
Source: AYAOPRG, 2006.
The spectrum of tumors seen in AYAs differs from that of childhood or older adults
(Bleyer et al., 2008). The majority of these cancers spontaneously occur and are not related to
environmental carcinogens or family history (Bleyer, 2007). Roughly 90% of the tumor types
exhibited in AYAs stem from 10 groups of cancers: breast, lymphoma, melanoma, ovarian and
cervical, thyroid, sarcomas, testicular, colorectal, leukemia, and brain tumors (AYAOPRG,
2006; Bleyer et al., 2008). Figure 1.3 illustrates the composition of cancer types in AYAs
(adapted from Bleyer et al., 2008). Bleyer et al. (2008) illustrate the cancer types that occur most
frequently in AYAs. Other age groups do not exhibit this distinct pattern of cancer types in
terms of the most common cancers.
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Figure 1.3. Occurrence of the Most Common Types of Cancer in AYAs, 1992-2002 (Adapted
from Bleyer et al., 2008).
The incidence of tumor types varies greatly across the AYA age spectrum (AYAOPRG,
2006; Bleyer et al., 2008). Older adolescents (age 15-19) suffer more from lymphomas, germ
cell tumors, and leukemias while young adults (age 20-39) have higher levels of carcinomas
(AYAOPRG, 2006). The incidence of cancer in the AYA age group has increased consistently
over the past 25 years (Bleyer et al., 2006). Males in the 15-29 age range are more likely to be
diagnosed with cancer as compared to females (Bleyer et al., 2006). Additionally, Caucasians
were more likely to be diagnosed with cancer than other ethnicities (AYAOPRG, 2006; Bleyer et
al., 2006). Meanwhile, American Indians and Alaskan natives have the lowest cancer incidence
(AYAOPRG, 2006). Figure 1.4 highlights the common cancer types in AYAs broken down by
age group (AYAOPRG, 2006).
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Figure 1.4. Common Types of Cancers Affecting AYAs in the United States by Age Group
Source: AYAOPRG, 2006.
Approximately two thirds of the tumor types in AYAs are represented by the following
six cancers: breast, lymphoma, melanoma, thyroid, and male and female gonadal cancers
(testicular and ovarian cancer, respectively) (Johnson, 2011). This research focuses on five of
those leading cancer types: breast, lymphomas, melanoma, testicular, and thyroid.
Breast Cancer
Breast cancer is a cancer that arises from the functional tissue elements of the breast
(NCI, 2012b). Over 200,000 new cases of breast cancer are diagnosed in females of all ages
each year and approximately 7% of those occur in AYAs (NCI, 2012b; Susan G. Komen for the
Cure, 2012). Overall, breast cancer accounts for 14% of cancers in AYAs (Bleyer et al., 2008).
The causes of breast cancer are not fully understood; however, several risk factors have been
24

identified (Susan G. Komen for the Cure, 2012). Risk factors include being a woman, age,
family history, genetic mutations, race, lack of physical activity, and consumption of alcohol
(NCI, 2012b; Susan G. Komen for the Cure, 2012). Young women (< 45 years of age)
diagnosed with breast cancer are more likely to have larger, less hormone sensitive tumors that
have spread to the lymph nodes as compared to older women (Anders et al., 2008). Additionally,
breast cancer in women under age 45 has unique biological characteristics that are different from
older women (Anders et al., 2008). Women diagnosed with breast cancer prior to age 45 tend to
have a worse prognosis that is independent of stage at diagnosis and histology type (Bleyer et al.,
2008).
Lymphomas
Cancers that arise from the lymphocytes of the immune system are classified as
lymphomas (NCI, 2012c). Lymphomas are subdivided into two main types: 1) Hodgkin
lymphoma (HL), characterized by the presence of Reed-Sternberg cells, and 2) non-Hodgkin
lymphoma (NHL) that includes all other lymphocytic cancers (NCI, 2012c). NHL is more
common than HL and is the seventh most common cancer in the US the age-adjusted incidence
of NHL has increased by more than 82.5% from 1975-2008 (LLS, 2012). Incidence rates of
lymphoma from 1999-2008 were higher for AYAs ages 20-24 as compared to ages 15-19 years,
7.6 and 4.8 per 100,000, respectively (LLS, 2012). Additionally, from 1999-2008 there has been
an overall increase in lymphoma for all ages in the AYA population (LLS, 2012). Lymphomas
account for 13% of cancers in AYAs (Bleyer et al., 2008). Risk factors for lymphoma are
currently unknown (LLS, 2012).
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Melanoma
Melanoma is defined by the uncontrolled growth of melanocytes (American Melanoma
Foundation, 2006; NCI, 2012d). Early detection and treatment of melanoma generally results in
a favorable prognosis (Bleyer et al., 2006). Melanoma is a common and mainly preventable
disease; it is the third most commonly diagnosed cancer in AYAs, accounting for 10% of AYA
cancers (Bleyer et al., 2008; Plescia, Berman, & White, 2011; Weir et al., 2011). Well known
risk factors for melanoma include: overexposure to ultraviolet (UV) radiation from sunlight or
artificial sources, family history of melanoma, light hair and skin color, tendency to develop
freckles, and immunosuppression (Gilchrest, Eller, Geller, & Yaar, 1999; Lin, Hocker, Singh, &
Tsao, 2008; Weir et al., 2011). The incidence of melanoma is highest in Caucasians as compared
to all other racial groups, regardless of age (Surveillance, Epidemiology, and End Results,
2011b; Weir et al., 2011). The occurrence of melanomas in AYAs suggest that early risk factors
play an important role, especially the potential for gene-environment interactions due to
increased UV exposure from sunlight or tanning beds and accumulated lifelong UV exposure
(Anderson, Pfeiffer, Tucker, & Rosenberg, 2009; Weir et al., 2011).
Testicular Cancer
Testicular cancer is a cancer that arises from the germ cells in the testes (NCI, 2012e).
Because this cancer arises in the germ cells, it is classified as a germ cell tumor. Testicular
cancer is usually diagnosed in young or middle aged men and accounts for 7% of all AYA
cancer cases (Bleyer et al., 2008; NCI, 2012e). Risk factors for testicular cancer include:
cryptorchidism (undescended testicle), race, and personal and family history. However; most
men with testicular cancer do not have any of the foregoing risk factors (ACS, 2012). The risk
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of testicular cancer is roughly five times higher in Caucasians as compared to African-Americans
and three times higher than Asian-Americans (ACS, 2012).
Thyroid Cancer
Thyroid cancer is one of the most frequently diagnosed cancers in adolescents and young
adults (AYAs) and accounts for roughly 10% of all cases (AYAOPRG, 2006; Bleyer et al., 2005;
Bleyer et al., 2008; Wu et al., 2005). Thyroid cancer is the fifth most commonly diagnosed
cancer in females of all ages (Jemal, Siegal, Xu, & Ward, 2010). Thyroid cancer arises from the
thyroid gland located at the front of the lower neck. The thyroid gland uses iodine to produce
several important metabolic hormones that are responsible for controlling heart rate, body
temperature, metabolism, and the level of calcium in the blood (NCI, 2011b). Risk factors for
thyroid cancer include a history of having an enlarged thyroid, family history of thyroid cancer
or thyroid disease, specific genetic conditions, exposure to radiation, individuals ages 25-65,
being Asian, and being female (NCI, 2011b; PubMed Health, 2011). The prognosis of thyroid
cancer is dependent on histology type, size of nodule or tumor, and stage at diagnosis (NCI,
2011b).
The spectrum of cancers that occur in AYAs is a distinctive assortment of tumors and the
reasons why these specific cancer types occur more frequently in AYAs compared to other age
groups is currently unknown (Hayes-Lattin, 2011). Moreover, the types of cancers that are
typically seen in older adults tend to behave differently biologically when occurring in AYAs
(Hayes-Lattin, 2011). For example, breast cancers diagnosed in AYAs have gene alterations and
behave differently than in older females (LSYAA, 2006). Biological differences in the spectrum
of cancers typically seen in AYAs could account for some of the suboptimal outcomes that
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AYAs are experiencing; however, additional research is needed to explain this phenomenon
(LSYAA, 2006).
Adolescent and Young Adult Cancer Care
AYAs with cancer are currently seen as a distinct group within the national and
international health agenda (Morgan, Robert, & Stahlschmidt, 2008). However, this group poses
a unique challenge to current health systems and the treatment teams providing care (Palmer et
al., 2007). This population falls into a gap within the healthcare setting and is difficult to classify
as either pediatric or adult; this results in difficulty in developing an appropriate treatment
approach for this age group (Whelan, Dolbear, Mak, Moller, & Davies, 2007). The range of
cancer diagnoses and treatments in AYAs is derived from both pediatric and adult oncology
practice and specialists must collaborate to deliver what is appropriate for tumor type and the
individual patient (Stevens, 2006). The treatment protocols used for AYA patients can vary
widely depending on whether pediatric or adult protocols are used and these differences can play
a significant role in the outcome of the patient (Bleyer et al., 2008). AYAs seem to have fallen
between the cracks in healthcare, being denied the benefits of inclusion in protocols and optimal
supportive care (Newburger, Elfenbein, & Boxer, 2002).
In order to best identify the healthcare needs of cancer patients, extensive information must
be gathered regarding the biological and psychosocial circumstances during the time when
cancer was diagnosed (Zebrack, Bleyer, Albritton, Medearis, & Tang, 2006). Due to the lack of
specific biological research on AYA cancers, it is difficult to identify the best course of treatment
(LSYAA, 2006). Additional research and increased knowledge of tumor biology could lead to
improved treatment protocols for AYAs (LSYAA, 2006). Most health professionals in oncology
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are not familiar with caring for AYAs due to the relative rarity of disease in this population.
However, these professionals acknowledge that AYAs with cancer are a unique group and have
different needs from cancer patients of other age groups (Whelan, 2003).
Little is known about where AYAs receive their initial treatment for cancer (Whelan et al.,
2007). Bleyer (2010) states the majority of young AYAs (age 15-19) with cancer are not being
referred to the appropriate specialist based on their cancer type. Although specific treatment
facilities and teams are occasionally available for young AYAs, they are not always used
(Whelan et al., 2007). It has been observed that in medical practice the unique characteristics of
AYAs have not been as fully acknowledged as in other arenas, such as the educational and
criminal justice systems and the commercial world (Whiteson, 2003). In comparison, childhood
cancer has been recognized by the medical profession as a distinct, separate field since the 1950s
and adults with cancer became a national priority with the National Cancer Act of 1971 (Bleyer,
2011; National Cancer Act, 1971).
AYAs typically find themselves treated on either a pediatric or adult unit, potentially
feeling isolated and having their physical, psychological, and emotional needs being neglected
(Brierley et al., 2009). The choice as to whether an AYA patient is cared for by a pediatric or
adult oncologist typically depends on the decision made by the referring physician (Bleyer,
2007). During the initial diagnosis process, AYAs may see a variety of practitioners, internists,
general practitioners, pediatricians, emergency room physicians, and a wealth of other specialists
(AYAOPRG, 2006; Bleyer, 2007). Following a cancer diagnosis, the treatment approach is very
inconsistent and AYAs may be treated by adult or pediatric oncologists, or radiation, surgical or
gynecological oncologists (AYAOPRG, 2006; LSYAA, 2006).
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The decision regarding the setting in which an AYA should be treated should be based on
which facility and practitioner will provide the best outcomes for the patient (Bleyer, 2007).
Depending on where the AYA patient is referred, the physician chosen to treat an AYA cancer
patient may or may not be as familiar with the correct approach to treatment (Albritton, 2005).
Specific cancer types such as acute lymphoblastic leukemia (ALL), Ewing’s sarcoma, and nonHodgkin lymphoma have been shown to have better outcomes for AYAs when treated according
to pediatric protocols rather than those for adult cancer patients (Bleyer, 2007). Furthermore,
treatment protocols for AYAs are not deliberately administered. Younger AYAs who suffer
from pediatric tumors do not have explicit provisions for receiving pediatric or adult dosages or
schedules of chemotherapy and radiation (AYAOPRG, 2006). Adult oncologists may be less
aggressive with chemotherapy dosages compared to pediatric oncologists when treating AYAs
because they are used to treating older patients who are not as healthy (Bleyer, 2007). Currently
there is a lack of data on AYA outcomes based on treatment teams, protocols, and settings
although these factors may distinctly affect overall outcomes (AYAOPRG, 2006).
Awareness is increasing that AYAs fall into a care gap between pediatric and adult cancer
services (Bleyer, 2011; Hayes-Lattin, 2011; Smith, 2004). However, there is still a need for
AYA cancers to receive much more national attention regarding the approach to cancer treatment
and care. Internationally, AYAs have received more attention, particularly in the United
Kingdom. The United Kingdom’s Teenage Cancer Trust (TCT) has made more specific
provisions for AYA (ages 13-24) cancers by providing age-specific cancer treatment and care for
AYAs administered by a treatment team trained in AYA cancer management (Bleyer, 2007;
TCT, 2011). The TCT found that AYAs have better survival rates when treated by practitioners
who specialize in AYAs with care provided by a multi-disciplinary treatment team in a distinct
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AYA cancer unit (TCT, 2011). This model has recently been adopted by the government to be
replicated throughout the United Kingdom (Bleyer, 2007).
The appropriate care setting and treatment team will vary for AYA cancer patients on a
case by case basis (Bleyer, 2007). However, distinct treatment protocols, teams, and care
settings should be established to provide optimal care for AYAs with cancer in the US (LSYAA,
2006). Ideally, AYA oncology should be seen as a separate field from pediatric and adult
oncology with separate training programs, clinical trials, and research (Bleyer, 2007).
Barriers to Progress in Adolescent and Young Adult Cancer
Progress in the field of AYA cancer has been stagnant due to a variety of reasons, which
include a lack of research and awareness. However, a multitude of additional factors specific to
this age range also play a role in the barriers to progress. Health insurance issues, delayed
diagnoses, the lack of participation in clinical trials, and the dynamic psychosocial needs of this
age group are important factors that influence AYA cancer survivorship in the United States
(LSYAA, 2006).
Insurance
Due to the uniqueness and transitional issues of this age group, AYAs are the most
underinsured of any age group in the US (Siegal, 2011). Based on the lack of insurance, AYAs
are likely to have delays in cancer diagnosis and as a result to be diagnosed with later stage
disease (Martin et al., 2007). The lack of insurance plays a vital role in the difficulty of having
healthcare access for AYAs (AYAOPRG, 2006).
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Various factors contribute to the lack of insurance in the AYA population. Provisions in
the Affordable Care Act (ACA) may eventually assist with the lack of insurance in this
population. The ACA has made obtaining healthcare coverage easier for young adults by
allowing coverage on their parents’ policy extending to age 26 (DHHS, 2011). Nonetheless,
AYAs are currently still lacking consistent health coverage. Prior to the ACA policy in 2010,
AYAs that were not currently enrolled in school or over age 23 were no longer insured on their
parents’ insurance plan (AYAOPRG, 2006). In addition, state-based health insurance through
Medicaid discontinues coverage at age 19 (AYAOPRG, 2006). Furthermore, many AYAs over
26 are not employed at companies that offer health insurance plans (Siegal, 2011). In general,
many AYAs are not able to afford individual health insurance and if they can afford it, many
must choose high deductibles, further limiting the available health care resources (AYAOPRG,
2006).
Following a cancer diagnosis, AYAs that are uninsured or underinsured will find
themselves with major debts for medical procedures they are required to pay out of pocket
(AYAOPRG, 2006). Another problem is that a cancer diagnosis during the AYA life stage may
have continued impact on an individual’s ability to obtain health insurance and increase future
insurance rates because of a pre-existing condition (AYAOPRG, 2006). Lack of insurance or
inadequate insurance creates a multitude of negative outcomes for AYAs, including delayed
diagnosis, late stage diagnosis, and these can result in a need for increased treatments and
therapies with an overall increased likelihood of negative outcomes (Martin et al., 2007).
Delayed Diagnosis
Delays in diagnosis occur more frequently in AYA cancer patients than in other age groups
(Martin et al., 2007). Individuals in the AYA age range are typically healthy; therefore, cancer
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symptoms are often overlooked and AYAs are likely to experience misdiagnosis of their cancer
systems (AYAOPRG, 2006; LSYAA, 2006). Cancer symptoms in AYAs are usually attributed
to stress or fatigue and disregarded for months and possibly years (AYOPRG, 2006). Based on
the distinctive cancer types that occur in AYAs, the signs and symptoms also have unique
characteristics that differ from those of children or older adults (Bleyer, 2007).
The general symptoms of AYA cancers include: mass in the neck, testis, breast, or other
body part, swelling of the lymph glands, constant fatigue, or neurological deficit (Bleyer, 2007).
Unfortunately, because many AYAs do not have a primary care physician due to lack of
insurance or a transition of care from providers they may not know where to seek treatment
should these symptoms arise (AYAOPRG, 2006; Bleyer, 2007; LSYAA, 2006; Siegal, 2011).
Because the lack of regular care in the AYA population plays a role in delayed diagnosis and
resultant poor prognosis, AYAs should be aware that self-exams and detection play a vital role in
decreasing diagnostic time (Bleyer, 2007).
AYAs may minimize the importance of symptoms and delay seeking medical care due to a
belief that they are invincible (AYAOPRG, 2006; Albritton, 2005; Bleyer, 2007). In general,
society does not believe that young people in this age range are likely to be diagnosed with
cancer, so AYAs may not be advised to see a physician and symptoms may be overlooked
(Siegal, 2011). AYAs may also feel uncomfortable in seeking medical care for symptoms that
involve genitalia or the colon/rectum (AYAOPRG, 2006).
The interval between symptom onset and diagnosis increases with age, almost double the
time frame for younger AYAs, ages 15-19, when compared with children under age 15
(AYAOPRG, 2006). As has been discussed, delays in diagnosis for AYAs stem from provider
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and patient lack of knowledge. Physicians should be more aware of cancer symptoms and how
they persist in AYAs (LSYAA, 2006). Meanwhile, AYAs must be proactive about their medical
care and receive routine exams.
Clinical Trial Participation
Although cancer research and clinical trials have resulted in marked improvements of
survival rates in cancer patients, AYAs have not had much benefit from these gains due to low
rates of access and participation in clinical trials (Burke et al., 2007). Limited numbers of
clinical trials target AYA-specific cancers, resulting in little increased understanding regarding
the behavior of AYA cancers (Burke et al., 2007). It is not clear whether AYAs are not
participating in clinical trials due to a lack of trials for their age range, patient refusal to enroll, or
a lack of physician referral of AYAs to trials (Johnson, 2011).
AYAs would benefit from the conduct of clinical trials targeting their age group and this
should be a critical public health target (Bleyer et al., 1997). Although only 2% of AYAs with
cancer were given the opportunity to enroll in a clinical trial, over 50% of pediatric oncology
patients (under age 15) received treatment as part of participating in a clinical trial (AYAOPRG,
2006; Bleyer, 2011). Participation in clinical trials rapidly declines after the age of 14 (Bleyer et
al., 2006). Research shows that roughly 14% of AYA patients diagnosed with non-Hodgkin’s
lymphoma (NHL), Hodgkin’s lymphoma (HL), acute lymphoblastic leukemia (ALL), germ cell
cancer and osteo-Ewing and synovial sarcomas are enrolled in clinical trials during treatment
(Parsons, Harlan, Seibel, Stevens, & Keegan, 2011). However, that percentage declines rapidly
with age with 15-19 year olds having 34.3% participation, declining to only 8.8% for 20-24 year
olds, and eventually only 3.7% for ages 35-39 (Parsons et al., 2011).
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Adolescents and young adults are underrepresented in national tumor banks, resulting in a
lack of opportunity for tumors samples to be studied retrospectively (Burke et al., 2007). AYAs
would benefit from the collection and investigation of tumor specimens in order to better
understand AYA-specific biological features (Pollock & Birch, 2008). Less than 60% of the
expected numbers of tumor samples from AYAs are sent to the Cooperative Human Tissue
Network, limiting the ability of research that can be done retrospectively to study and identify
the characteristics of AYA tumors (Burke et al., 2007). While there are several explanations for
the insufficient amount of clinical trial research for AYAs, it is clear that there is a lack of trials
available for AYAs and that this group should be targeted for participation (Johnson, 2011).
Psychosocial Needs
When the burden of cancer is added during this distinct life stage, AYAs experience
extreme challenges in their growth and development (Bleyer et al., 2006). The necessary and
critical changes that occur during adolescence and young adulthood may be interrupted,
accelerated, or reversed by the cancer experience (Lewis, Fallon, Dongen-Melman, & Barr,
2002). The AYA years can be among the most difficult years of life in regard to self-identity,
maturity, and autonomy. These formative years involve a series of developmental stages during
which the individual gains personal identity, independence, sexual and emotional maturity, selfesteem, and future life opportunities (Mulhall, Kelly, & Pearce, 2004). This period of
development is susceptible to disturbance, as AYAs make the transition from childhood into
older adulthood while developing physically, psychologically, sexually, and socially (Evan,
Kaufman, Cook, & Zeltzer, 2006). Disruption of the development from childhood to adulthood
associated with developing cancer can severely impact an individual.

35

AYA cancer was once seen as an acute, invariably fatal disease, but is now regarded as a
chronic illness (Smith, 2004). Many AYAs diagnosed with cancer will be cured, often after
intensive, toxic, and life-changing treatment (Whelan, 2003). Cancer diagnosis during
adolescence and young adulthood exacerbates the difficulties of transitioning from childhood to
adulthood (AYAOPRG, 2006). Furthermore, a patient’s stage of life is directly associated with
how he or she understands, processes, and copes with a diagnosis of cancer (Palmer et al., 2007).
While a diagnosis of cancer is difficult during any life stage, the impact of cancer on AYAs
seems to be greater than other age groups. This age group consists of individuals with particular
emotional, social, and psychological problems, with diverse levels of maturity and differing
needs (Clerici et al., 2008).
A cancer diagnosis during the AYA life stage raises particular concerns because of the
impact on normal development, disruption of school and social activities, loss of self-identity,
and dependence on family and caregivers (Mulhall et al., 2004).

The multitude of challenges

and changes that occur during adolescence make young people susceptible to additional
pressures and stressors even without a cancer diagnosis (Palmer et al., 2007). Following the
transition from child to adulthood, AYAs are expected to emerge with a positive sense of selfworth, an established identity, comfortable body image, and the ability to form relationships
(Hollis & Morgan, 2001). Unfortunately, the diagnosis and treatment of a potentially terminal
illness such as cancer does not allow AYAs to progress through the developmental process
normally.
AYA cancer patients may not have a normal body image due to such reasons as surgical
scarring, weight fluctuations due to treatment, or loss of hair due to chemotherapy (AYAOPRG,
2006). Isolation from their peers during cancer treatment severely limits the development of
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social skills and sexual identity (Evan et al., 2006). Other areas that may be impacted include
achieving emotional independence from their parents and developing a decision making process
that is uniquely their own (Evan et al., 2006). For most AYAs, the cancer diagnosis is the first
time they have faced their own mortality (AYAOPRG, 2006).
Summary
The combination of adolescence or young adulthood with a diagnosis of cancer provides
a unique situation that requires a specific model of care. The developmental processes
experienced by AYA cancer patients differ from the experience of children or older adults with
cancer. AYAs have a variety of distinct healthcare needs that must be understood and addressed
while providing cancer treatment (AYAOPRG, 2006). The needs of AYA cancer patients are
dynamic and comprise physical, psychological, social, and educational needs. Often, these needs
are overlooked, leaving AYAs anxious about obtaining information regarding their cancer,
treatment and treatment options, peer relationships and psychosocial support, as well as other
important general information. Hodgkinson (2007) highlights that increased recognition of the
psychosocial impact of cancer has motivated practitioners to broadly assess individuals' needs in
order to provide more supportive care services. It is very important that the medical and
psychosocial needs of AYA cancer patients are addressed by practitioners and researchers who
understand those needs.
Cancer in AYAs is a major public health concern that has been overlooked by the
medical and research communities for years (AYAOPRG, 2006). The recent gains in awareness
for AYAs through the AYAOPRG and the LSYAA illustrate that AYA cancer is a unique field
that requires attention. AYA patients are in need of cancer-specific, age-appropriate care and
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increased awareness campaigns to achieve progress in their treatment outcomes. Reversing the
past trend in the approach to AYA cancer care and decreasing the “AYA Gap”, consisting of the
lack of progress in cancer outcomes as compared to other age groups, must involve
comprehensive efforts from multiple stakeholders, including the government, insurance agencies,
healthcare providers, and researchers (Ferrari, Montello, Budd, & Bleyer, 2008; Pollock & Birch,
2008).
Significance to Public Health
AYA cancer patients have received inadequate attention in the areas of cancer research,
interventions, and awareness. While historically AYAs have typically seen positive survival
outcomes as compared to other age groups, there has been a significant lack of progress in the
survival rates of AYAs since 1975 (AYAOPRG, 2006; Bleyer, 2002). Over the past 20 years the
survival rates for children and older adults have improved significantly, while the survival rates
of AYAs have remained stagnant (LSYAA, 2006). Understanding the cancer incidence in AYAs
may provide insight into their future cancer burden (Weir et al., 2011). Investigation of AYA
cancer has the potential to provide insight into the etiology of certain cancer types, especially
since the interval between exposure and diagnosis may be shorter (Weir et al., 2011). Examining
the incidence and prevalence of cancer in the AYA population in Tennessee will provide
evidence at the state level for understanding the overall cancer burden in this specific population.
Using a state-based cancer registry to provide a state profile of AYA cancers will provide a
resource for future state-based cancer interventions and cancer control.
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Human Subjects Protection
The East Tennessee State University and Veteran’s Administration Institutional Review
Board (IRB) reviewed this study and it was exempt on the basis of not representing human
subjects’ research. The data were collected by the state cancer registry and all identifying
information on individuals was removed prior to being provided for the current study.
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ABSTRACT
Purpose: Adolescents and Young Adults (AYAs) are an underserved and underrepresented
population in cancer care. Understanding the unique cancer burden in this population in
Tennessee will help to improve cancer prevention and control efforts. Patients and Methods:
Tennessee Cancer Registry data for 2004-2008 were used to determine incidence rates of the five
most frequently diagnosed cancers in AYAs: breast, lymphoma, melanoma, testicular, and
thyroid. Cancers were coded by ICD-O-3 codes. Cancer-specific incidence rates were
determined according to age, gender, and year of diagnosis. Age-adjusted rates were calculated
by cancer type using the US 2000 Standard Population.

Results: For 2004-2008, breast cancers

(15.0%) were the most common AYA cancers, followed by melanomas (13.7%), thyroid cancers
(10.3%), lymphomas (7.7%), testicular cancers (6.1%), and all other cancer types (47.3%).
Adjusted incidence rates for melanomas were higher in females than males (AIR 14.01, CI
12.96-15.06 vs. AIR 8.08, CI 7.28-8.88, respectively) as were thyroid cancers (AIR 13.39, CI
12.37-14.42 vs. AIR 3.50, CI 2.98-4.03, respectively). Incidence rates for all cancer types
increased with age. Conclusion: The types of cancers diagnosed in AYAs in Tennessee are
similar to those diagnosed in the United States. The incidence of melanoma and thyroid cancers
are higher in Tennessee compared to the United States and both are higher in females than males.
Identifying the types of cancer most often diagnosed in AYAs in Tennessee will help focus the
direction of future research and provide a basis for the development of cancer prevention and
control activities for this population.
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Background
Cancer in adolescents and young adults (AYAs) is a major public health concern that
has not been effectively addressed by the medical and research communities (AYAOPRG,
2006). The recent increased awareness of AYA cancer resulting from the Adolescent and Young
Adult Oncology Peer Review Group (AYAOPRG) and the Live Strong Young Adult Alliance
(LSYAA) activities, emphasizes the need for more attention to this area (AYAOPRG, 2006;
LYSAA, 2006). Despite the recent attention and recognition of the distinctive health care needs
of this population, there is still much to be understood about AYA cancer (Wu et al., 2005).
Little is known about the AYA population and factors that play a role in the biologic,
epidemiologic, genetic, psychosocial, and economic issues that underlie their morbidity,
mortality, and quality of life (AYAOPRG, 2006). Cancer in AYAs has distinct features and the
spectrum of malignant disease in this population is much different than for other age groups
(Bleyer, 2002). The disruption caused by a cancer diagnosis during this phase of life presents
the patients with unique psychosocial, medical, physical, and educational needs (Bleyer, 2002).
Definition of Adolescents and Young Adults
The definition of AYAs has evolved over the years, with many different definitions
existing based on age, psychosocial development, and societal influences (AYAOPRG, 2006).
The Adolescent and Young Adult Oncology Progress Review Group and the National Cancer
Institute have defined AYAs over a wide age range, 15-39 years of age, in order to be include the
entire spectrum of cancer patients that continue to experience a lack of improvement in cancer
care and survival (AYAOPRG, 2006; NCI, 2012a). Although this age range may seem quite
wide, individuals in this population are similar based on extreme differences in the diagnosis and
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treatment of cancer as compared to other age groups (Wolfson, 2011). Prior to the development
of this AYA definition, individuals in this age range lacked a home in cancer care and research,
and were usually treated by either pediatric or adult protocols based solely on their cancer
diagnosis (AYAOPRG, 2006). This formal definition of AYAs will help to focus attention and
streamline research, interventions, treatment, and awareness efforts in this population
(AYAOPRG, 2006).
Epidemiology
The spectrum of tumors seen in AYAs differs from that of either childhood or older adults
(Bleyer et al., 2008). The majority of these cancers appear to occur spontaneously and there is
not the relationship to environmental carcinogens and family history seen with adult cancers
(Bleyer, 2007). About 90% of the tumor types exhibited in AYAs are from ten cancer types:
breast, lymphoma, melanoma, ovarian and cervical, thyroid, sarcomas, testicular, colorectal,
leukemia, and brain tumors (AYAOPRG, 2006; Bleyer et al., 2008). In addition, approximately
two-thirds of AYA cancers are from only six of the aforementioned types: breast, lymphoma,
melanoma, thyroid, and male and female gonadal cancers (Johnson, 2011). The incidence of
tumor types varies greatly across the AYA age spectrum (AYAOPRG, 2006; Bleyer et al., 2008).
Older adolescents (age 15-19 years) suffer more from lymphomas, germ cell tumors, and
leukemias as compared to higher levels of carcinomas that occur in young adults (age 20-39)
(AYAOPRG, 2006). Males in the 15-29 year old age range are more likely to be diagnosed with
cancer compared to females (Bleyer et al., 2006; Bleyer, Viny, & Barr, 2006). Additionally,
Caucasians were more likely to be diagnosed with cancer than other ethnicities (AYAOPRG,
2006; Bleyer et al., 2006).
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Tennessee
Tennessee (TN) provides a unique opportunity to investigate AYA cancer since the state
has distinct geographic and demographic differences. Tennessee encompasses major
metropolitan areas, suburban counties, and rural communities located in the Appalachian
Mountains and the Mississippi Delta region. Overall, TN is comprised of about 80% Caucasians
and has less than 20% African-American people (Erwin et al., 2010). East TN has a relatively
homogenous Caucasian population, even in major urban areas like Knoxville (Erwin et al.,
2010). Meanwhile, in West TN the percentage of Blacks is proportionally higher than for the
overall state with around 50% African-Americans reported (Erwin et al., 2010). Only 27 of TN’s
95 counties are considered urban, while 68 are rural (Erwin et al., 2010).
The Tennessee Cancer Registry (TCR) reported that TN has the twenty-second highest
age-adjusted cancer incidence rate and the fifth highest cancer mortality rate in the nation (Li et
al., 2010). The TCR report shows that children age 0-4 and adolescents age 15-19 have the
highest incidence rates for cancers of childhood. However, cancer mortality rates are relatively
similar across all cancers that are diagnosed prior to age 20 (Li et al., 2010). There has been no
research in TN that has specifically investigated the AYAs, age 15-39 years, to help understand
the unique characteristics of cancer in this population. Although TN is well known in cancer
control and prevention due to nationally recognized cancer centers such as St. Jude’s Children’s
Research Hospital and Vanderbilt- Ingram Cancer Center, as well as an established state-wide
cancer coalition, the burden of cancer in AYAs has not been fully investigated and therefore is
not well understood.
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Further epidemiologic research focused on AYAs is needed to better understand the
cancer burden, patterns and trends and the barriers to progress in cancer prevention and control.
This study examines the cancer incidence and patterns for AYAs in TN for 2004 through 2008.
The five most common cancers were evaluated, including breast, lymphoma, melanoma,
testicular, and thyroid. A better understanding of the types of cancer that affect AYAs along
with characteristics of the cancer patients will provide an evidenced-based approach for future
cancer research and interventions.
Patients and Methods
Data Source
Data were obtained from the TCR for all new AYA cancer cases in TN from 2004
through 2008. The TCR is part of the National Program of Cancer Registries (NPCR) (CDC,
2012). The NPCR was established in 1992 through the Cancer Registries Amendment Act and
works to provide cancer surveillance across the nation (CDC, 2012). Administered by the
Centers for Disease Control and Prevention (CDC), state based cancer registries monitor cancer
trends over time; determine patterns of cancer incidence and mortality in specific populations,
and assist in the planning and evaluation of cancer control programs (CDC, 2012).
The NPCR falls under the jurisdiction of the North American Association of Cancer
Registries (NAACR) for standardization of registry data (Thornton, 2010). Standardization of
cancer registry data is a vital component of cancer surveillance quality as it provides the basis for
having consistent data across cancer registries in North America (Thornton, 2010). The NAACR
has developed uniform data standards and an associated data dictionary for the use of all cancer
registries in North America. This document serves as a reference to ensure uniform data
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collection, assist in the collection of data that is comparable across groups, provide a resource for
state based registries, and to reduce redundancy in the coding and collection of data.
Furthermore, state registry data must meet NAACR standards of completeness (90%
completeness of the data set) in order to be accepted for NAACR/CDC publication (Hofferkamp,
2008).
The TCR met data completeness standards for the first time in 2004 and have continued
to produce high quality data since then (Li et al., 2010). Data for the current study, years 20042008, met data completeness standards of 95% or higher (Li et al., 2010). The TCR collects data
on cancer incidence, including: the type of cancer, primary site of cancer, stage, first course of
treatment, vital status, and general demographic information (Li et al., 2010). Data are sent to
the TCR from hospitals, pathology labs, physician’s offices, and radiation facilities (Li et al.,
2010). The information on each case is compiled into the database to provide cancer statistics
for the state.
Sample
The sample for this study included all new breast cancer, lymphoma, melanoma,
testicular, and thyroid cancer cases (N=4,269) in AYAs from the Tennessee Cancer Registry for
the years 2004-2008, inclusive. AYA cases were defined as cancer cases that were diagnosed in
individuals ages 15-39 years, inclusive. Both in situ and invasive cancer cases in the AYA
population are included. Cancer primary sites were identified by International Classification of
Disease for Oncology, Third Edition (ICD-O-3). Hodgkin and non-Hodgkin lymphoma were
combined and referred to as lymphomas. General demographic information including gender,
age, and insurance status, county of diagnosis, marital status, and race were reported for each
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case. Cancer specific information such as primary cancer site, stage at diagnosis, treatment type,
and vital status are also reported for each case.
Analyses
Secondary data analysis of the AYA data set was performed using SAS 9.2 (SAS
Institute, 2009). Crude incidence rates (CIR), defined as the total number of incident cases
divided by the mid-year population, were calculated for each cancer. Age specific incidence rates
(ASIRs), the ratio of the number of new cases in a specific age group to the population of that
group, were calculated for each cancer by sex. Consistent with current AYA cancer research,
ASIRs were calculated for the following five age groups: 15-19, 20-24, 25-29, 30-34, and 35-39.
To compare rates across different groups, age adjusted incidence rates (AIR) for each cancer
type and year of diagnosis by gender were calculated using the US 2000 standard population.
Overall adjusted incidence rates for the 2004-2008 study period for each cancer by gender were
calculated using the US 2000 standard population. All rates are expressed per 100,000
population. Confidence intervals (CI 95%) for AIRs were calculated to compare rates across
populations and diagnosis years. Rates were not calculated by race due to inadequate
information for this variable in the sample.
Results
A total of 8,097 cancers were diagnosed in AYAs in TN from 2004-2008. About half of
those cancers (4,269 or 52.7%) were of the five following types: breast, lymphomas, melanoma,
testicular, and thyroid. Table 1.1 illustrates the distribution of the top five cancers and the
characteristics of those with cancer. The sample included 1,216 breast cancers (15.0%), 1109
melanomas (13.7%), 830 thyroid cancers (10.3%), 623 lymphomas (7.7%) and 491 testicular
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cancers (6.1%). The majority of cancer cases were female (66.8%), diagnosed with localized
stage cancer (59.3%), and were Caucasian (85.7%).
Table 1.1. Characteristics of the Five Leading AYA Cancers in Tennessee, 2004-2008
N= 4,269
Characteristics
Primary Site*

N (%)

Breast
Lymphomas
Melanoma
Testicular
Thyroid
Age at diagnosis (years)
15-19
20-24
25-29
30-34
35-39
Sex
Female
Male
Race
Caucasian
Other
Region
Non-Appalachian
Appalachian
Stage
In Situ
Local
Regional/Distant
Insurance Status
Not Insured
Government Insurance
Private/Other

1216 (15.0)
623 (7.7)
1109(13.7)
491 (6.1)
830 (10.3)
174 (4.1)
449 (10.5)
710 (16.6)
1151 (27.0)
1785 (41.8)
2851 (66.8)
1416 (33.2)
3620 (85.7)
602(14.3)
2353 (55.1)
1916 (44.9)
172 (9.3)
1093 (59.3)
577 (31.3)

219 (6.2)
587 (16.7)
2717 (77.1)

Year of Diagnosis
2004
793 (18.6)
2005
859 (20.1)
2006
880 (20.6)
2007
882 (20.7)
2008
855 (20.0)
*Based on the total number of cancers in AYAs in TN.
Other cancer types accounted for 52.8% or 3828 cases.
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Table 1.2 shows the incidence rates for female breast cancer from 2004-2008. Agespecific breast cancer rates increased as age increased. Age 35-39 had the highest incidence
rates while ages 15-19 had the lowest rates. Breast cancer incidence in TN drastically increases
with age from 0.30 cases per 100,000 in ages 15-19 to 72.30 cases per 100,000 in 35-39 year
olds. The incidence of breast cancer remained consistent throughout the duration of the study
period and did not significantly increase from 2004-2008.
Table 1.2. AYA Female Breast Cancer Incidence Rates^ for Tennessee by Age and Year of Diagnosis
Year
Sex & Age

2004

2005

2006

2007

2008

All

15-19

0.51

1.01

0.0

0.0

0.0

0.30

20-24

1.56

2.56

1.01

2.01

2.00

1.82

25-29

14.06

12.00

11.86

9.21

11.68

11.75

30-34

32.38

30.32

30.80

34.92

31.56

32.00

35-39

66.50

77.78

78.34

67.27

71.68

72.30

All*

24.56

26.63

26.33

24.35

25.12

25.39

(21.42-27.71)

(23.33-29.93)

(23.06-29.61)

(21.20-27.49)

(21.92-28.32)

(23.96-26.83)**

(N=1209)

^per 100,000, *Age adjusted incidence rate using US 2000 standard population for all age groups, **Age
adjusted incidence rate using US 2000 standard population for all age groups and for all five years (20042008).

Table 1.3 shows that lymphoma rates in AYAs in TN remained similar and did not
significantly increase during the study period. Although males displayed consistently higher
incidence rates than females, the differences were not significant at the p < 0.05 level. The
overall adjusted rate for males was 6.53 (5.82-7.24) and for females was 5.38 (4.73-6.02). In
general, incidence rates of lymphoma steadily increased by age for both males and females.
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Table 1.3. AYA Lymphoma Incidence Rates^ for Tennessee by Gender, Age, and Year of Diagnosis
Year
Sex & Age

2004

2005

2006

2007

2008

All

15-19

1.94

3.36

3.79

3.29

6.51

3.80

20-24

5.57

7.00

6.92

3.93

4.88

5.65

25-29

5.16

4.65

5.61

5.06

6.02

5.31

30-34

9.90

5.92

7.39

10.89

7.45

8.31

35-39

7.74

12.71

5.34

9.21

10.65

9.13

6.12

6.92

5.78

6.60

7.25

6.53

(4.58-7.66)

(5.27-8.56)

(4.30-7.26)

(5.00-8.20)

(5.58-8.92)

(5.82-7.24)**

15-19

3.59

6.09

2.50

3.47

3.43

3.81

20-24

5.70

4.61

4.05

7.54

3.49

5.08

25-29

7.81

5.74

3.09

5.12

4.06

5.15

30-35

4.98

7.96

5.96

4.99

5.51

5.88

35-39

3.82

8.26

8.22

8.71

4.84

6.77

5.08

6.62

4.89

4.50

4.30

5.38

(3.69-6.48)

(5.01-8.23)

(3.51-6.28)

(6.03-7.56)

(3.01-5.58)

(4.73-6.02)**

Males (N=345)

All*
Females (N=278)

All*

^per 100,000, *Age adjusted incidence rate using US 2000 standard population for all age groups, **Age
adjusted incidence rate using US 2000 standard population for all age groups and for all five years (20042008).

Table 1.4 illustrates the melanoma cases in TN from 2004-2008 by age and gender.
Melanoma rates were higher for females in every age group. Females also displayed higher rates
for each year of diagnosis. The overall AIR for males is 8.08 (CI 7.28-8.88) and for females is
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14.01 (CI 12.96-15.06), showing statistical significance at the 0.05 level. Melanoma incidence
rates increased with age for both males and females increase.
Table 1.4. AYA Melanoma Incidence Rates^ for Tennessee by Gender, Age, and Year of Diagnosis
Year
2004

2005

2006

2007

2008

All

15-19

2.92

0.96

1.89

2.35

0.93

1.80

20-24

4.05

4.5

2.47

3.44

3.42

3.57

25-29

5.67

7.75

12.76

3.54

6.52

7.24

30-34

8.91

10.84

9.85

9.4

12.42

10.28

35-39

19.34

15.65

15.05

15.03

15.5

16.12

8.57

8.18

8.56

7.07

8.03

8.08

(6.72-10.41)

(6.38-9.97)

(6.74-10.39)

(5.40-8.74)

(6.25-9.80)

(7.28-8.88)**

15-19

2.05

2.03

3.5

1.49

1.96

2.20

20-24

10.89

10.77

9.62

11.56

9.98

10.56

25-29

11.46

14.08

17.53

14.32

11.68

13.81

30-34

16.94

16.41

20.87

22.95

16.53

18.74

35-39

17.7

20.42

24.18

28.07

26.64

23.39

11.96

12.92

15.38

16.05

13.76

14.01

(9.80-14.12)

(10.67-15.17)

(12.93-17.83)

(13.54-18.56)

(11.43-16.09)

(12.96-15.06)**

Sex & Age
Males (N=401)

All*
Females (N=707)

All*

^per 100,000, *Age adjusted incidence rate using US 2000 standard population for all age groups, **Age
adjusted incidence rate using US 2000 standard population for all age groups and for all five years (20042008).

Testicular cancer rates are displayed in Table 1.5. Testicular cancer rates were consistent
over the 5 year study period and did not significantly differ from 2004-2008. As with the other
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cancers previously discussed, testicular cancer incidence increases with age. However, testicular
cancer seems to peak at the 25-29 and 30-34 age groups, with those rates at 12.24 and 12.56 per
100,000, respectively. Incidence rates of testicular cancer are low in 15-19 year olds (2.66), but
increase markedly as age increases, with rates roughly four times higher in 30-34 year old age
group (12.56).
Table 1.5. AYA Testicular Cancer Incidence Rates^ for Tennessee by Age and Year of Diagnosis
Year
Sex & Age

2004

2005

2006

2007

2008

All

15-19

2.43

1.92

1.42

3.75

3.72

2.66

20-24

8.11

9.50

4.45

11.79

11.23

9.03

25-29

15.48

13.44

10.72

12.15

9.53

12.24

30-34

8.91

16.76

12.81

11.38

12.92

12.56

35-39

8.71

13.69

14.08

10.67

12.59

11.94

8.59

11.08

8.84

9.89

10.04

9.69

(9.01-13.15)

(6.99-10.69)

(7.95-11.82)

(8.09-12.00)

(8.83-10.55)**

(N=491)

All*

(6.78-10.40)

^per 100,000, *Age adjusted incidence rate using US 2000 standard population for all age groups, **Age
adjusted incidence rate using US 2000 standard population for all age groups and for all five years (20042008).

Table 1.6 displays thyroid cancers in TN by gender and age from 2004-2008. Females
were roughly 4 times more likely to be diagnosed with thyroid cancer compared to males, 12.37
(CI 13.39-14.42) and 3.50 (CI 2.98-4.03), respectively. These findings are significant at the 0.05
level. Females were more likely to be diagnosed with thyroid cancer at every age as compared
with males. Males and females both experienced increased incidence of thyroid cancer with
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increased age. Females in the 30-34 and 35-39 year old age brackets are almost twice as likely
to be diagnosed with thyroid cancer compared to any other age group.

Table 1.6. AYA Thyroid Cancer Incidence Rates^ for Tennessee by Gender, Age, and Year of Diagnosis

Year
Sex & Age

2004

2005

2006

2007

2008

All

15-19

0.49

1.44

0.0

0.47

0.0

0.47

20-24

1.52

1.00

1.98

1.47

1.46

1.49

25-29

5.16

2.58

3.06

6.58

2.51

3.98

30-34

3.46

3.94

4.43

5.93

6.46

4.85

35-39

4.35

6.84

5.34

8.24

6.78

6.31

3.00

3.30

3.03

4.63

3.57

3.50

(1.93-4.08)

(2.15-4.44)

(1.94-4.12)

(3.29-5.97)

(2.38-4.75)

(2.98-4.03)**

15-19

1.54

1.52

1.00

0.99

3.92

1.80

20-24

5.70

7.18

8.61

8.55

6.99

7.41

25-29

8.85

12.52

14.95

11.25

14.72

12.47

30-34

17.44

19.89

21.86

20.96

21.04

20.24

35-39

21.05

15.56

28.53

26.62

25.18

23.39

11.27

11.45

15.40

14.10

14.72

13.39

(9.16-13.38)

(9.33-13.56)

(12.94-17.86)

(12.32-17.13)

(12.32-17.13)

(12.37-14.42)**

Males (N=173)

All*
Females (N=657)

All*

^per 100,000, *Age adjusted incidence rate using US 2000 standard population for all age groups, **Age
adjusted incidence rate using US 2000 standard population for all age groups and for all five years (20042008).
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Discussion
The types of cancers that affect AYAs in TN are relatively similar to the types that affect
AYAs nationally; however, the distribution of those cancers differs slightly in TN. Bleyer
(2011) illustrate the distribution of the top five cancers in AYAs to be ranked in the following
order: breast, lymphomas, melanomas, female genital tract, and thyroid cancer. The top five
most frequently diagnosed cancers in AYAs in TN for 2004-2008 were breast, melanomas,
thyroid, lymphomas, and testicular cancers.
According to Bleyer, Viny, and Barr (2006), in the United States, males in the 15-29 age
range are more likely to be diagnosed with cancer compared to females. However, in TN for the
five cancers most frequently diagnosed, female AYAs (15-39 year old age range) are more likely
to be diagnosed with cancer as compared to males. The difference in age ranges examined
prevents a valid comparison and the increased cancers diagnosed in females at the upper limits of
the AYA age range may explain the difference. Lymphoma diagnoses were relatively similar by
gender; however, melanomas and thyroid cancers were diagnosed mostly in females.
In addition, the increased cancer incidence in AYA females compared to males is
predominately due to the fact that a large proportion of the cancers diagnosed during this study
period were female breast cancers. Incidence rates for female breast cancers in AYAs in TN
were higher than the national statistics in all age groups. Females aged 35-39 years in TN
reported an incidence rate of 72.30 per 100,000 compared to 59.97 per 100,000 nationally
(Surveillance, Epidemiology, and End Results, 2011a).
Melanomas were the second most frequently diagnosed cancer in AYAs in TN and
accounted for roughly 25% of the five most common cancers and 13.7% of all cancers diagnosed
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in AYAs. However, in the US, melanoma is the third most commonly diagnosed cancer in
AYAs (Weir et al., 2011). In all age categories, female AYAs in TN reported higher melanoma
incidence rates compared to the nation (Surveillance, Epidemiology, and End Results, 2011b).
The greatest difference in incidence rates in TN compared to the nation was for females aged 2024 years (10.56 vs. 5.80, respectively). Consistent with the current literature, melanoma
incidence rates in females proved to be significantly higher than rates for males in AYAs (Bleyer
et al., 2006; Weir et al., 2011; Wu et al., 2011). However, this finding is different compared to
older age groups where males are more commonly diagnosed, suggesting there may be
something unique about melanoma in AYA females (Jemal, Siegal, Xu, & Ward, 2010).
Thyroid cancer accounts for more than 10% of all cancers in the AYA population
nationally and is two to three times more common in females (AYAOPRG, 2006; Bleyer, 2005;
Tuttle et al., 2010; Wu et al., 2005). Nationally, thyroid cancer is the fifth most frequently
diagnosed cancer in females of all ages (Bleyer, 2011). In this sample, thyroid cancer was the
third most commonly diagnosed cancer, behind breast cancer and melanoma, respectively and
accounted for 10.3% of the cancers diagnosed in AYAs in TN during the study period. Thyroid
cancer incidence rates in females in TN ages 30-34 (20.24) and 35-39 (23.39) are slightly higher
than national incidence rates for ages 30-34 (18.19) and 35-39 (21.78). Additionally, thyroid
cancer was almost four times more common in AYA females compared to AYA males in TN.
Testicular cancer was also more frequently diagnosed in AYAs in TN compared to the
nation. Nationally, testicular cancers are the seventh most commonly diagnosed cancer in AYAs
(Bleyer, 2011). In this study testicular cancers were the fifth most commonly diagnosed cancer.
However, incidence rates for testicular cancer were similar to national rates for all races.
Incidence rates in TN from 2004-2008 were only marginally higher compared to national
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statistics from 2000-2008 for men 35-39 years of age (11.94 vs. 11.29) (Surveillance,
Epidemiology, and End Results, 2011a). Consistent with current literature, testicular cancers
were highest in males aged 20-34 (NCI, 2012e).
In conclusion, AYA cancers in TN represent a unique population in cancer occurrence.
Cancer types vary by gender and age in this population and are different from cancer types
affecting both younger and older age groups. Cancer incidence patterns in this age group are not
fully understood, but are more likely to be related to genetic predisposition and explicit health
behaviors associated with AYAs. Cancer prevention and control strategies should be agespecific and tailored for the needs of this group.
Strengths and Limitations
The use of the TN Cancer Registry provided high-quality data that met national standards
of the North American Association of Cancer Registries. The study provided useful information
on the unique characteristics of cancer in the AYA population in TN. This is the first study to
use the TN Cancer Registry to look at the distinct features of AYA cancer and to explore the
differences of AYAs in TN compared to national data.
As is true of all studies, this study has limitations. There was a lack of sufficient racial
diversity in the sample to allow for incidence rates to be calculated by race. These findings do
not supply information regarding potential racial disparities in AYA cancer. Future research that
includes additional socio-demographic and cancer specific variables related to diagnosis,
treatment, and stage will help to identify the barriers to progress in AYA cancers in TN.
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Public Health Implications
Identifying the main cancer types affecting AYAs in TN provides the opportunity to
adapt and customize cancer prevention and control efforts for this age group based on the types
of cancer that predominately occur in this population. Prevention activities should focus on
educating AYAs about the most commonly diagnosed cancers in their age range, risk factors,
and screening provisions. Four of the five types of cancer most commonly diagnosed in AYAs
in TN (breast, melanoma, thyroid, and testicular cancers) have known symptoms and screening
procedures that can be used to educate medical practitioners about approaches to incorporate into
their practice when treating AYAs. Finally, increasing awareness of the most commonly
diagnosed cancers in AYAs and the risk factors associated with those cancers will assist in
reducing the disparities connected to cancer among 15-39 year olds.
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ABSTRACT
Purpose: Melanoma is the second most commonly diagnosed cancer in adolescents and young
adults (AYAs) aged 15-39 years in the United States. This study’s objectives were to understand
the unique characteristics of melanoma in AYAs in Tennessee and to identify the predictors of
late-stage diagnosis. Patients and Methods: All (AYA) melanoma cases in Tennessee (N=1109)
were obtained from the Tennessee Cancer Registry for the years 2004-2008. Cases with a
confirmed stage of diagnosis (n=327) were included for analysis to determine predictors of latestage diagnosis, using the proportional odds model. Sex, insurance status, and age of diagnosis
served as predictors in the model. Results: The majority of melanoma cases (N=1109) were
female (63.8%), Caucasian (96.5%), diagnosed with localized stage cancer (69.3%), and were
diagnosed between the ages of 35-39 years (37.8%). Government insurance served as the
greatest predictor of late-stage melanoma diagnosis. Individuals with government insurance
were eight times (OR 8.41, CI 3.04-23.27, p<0.01) more likely to be diagnosed with late stage
melanoma compared to individuals with private or other types of insurance. Individuals
diagnosed with melanoma between ages 15 and 19 were six times (OR 6.30, CI1.74-22.86,
p<0.01) more likely to be diagnosed with late-stage melanoma compared to individuals in the
35-39 year old age group. Conclusion: These data suggest targeted areas for future research
regarding insurance status and age at diagnosis as predictors of late stage melanoma and the need
for cancer prevention and control activities geared towards AYAs.
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Background
Melanoma is an extremely common and chiefly preventable disease; however, it is still the
third most commonly diagnosed cancer in the adolescent and young adult (AYA) population
(Plescia et al., 2011; Weir et al., 2011). Increasing incidence of melanoma and trends in
melanoma mortality in the United States have motivated public health practitioners to focus on
early detection and prevention (Purdue, Freeman, Anderson, & Tucker, 2008; Koh & Geller,
2011). Melanoma is defined by the uncontrolled growth of melanocytes that can spread to other
parts of the body, potentially resulting in death (American Melanoma Foundation, 2006). Early
detection and treatment of melanoma generally yields a favorable prognosis (Bleyer et al., 2006).
The most well known risk factor for melanoma is overexposure to ultraviolet (UV)
radiation from sunlight or artificial sources (Gilchrest et al., 1999). Family history of melanoma,
light hair/skin color, tendency to develop freckles, and immunosuppression all pose an increased
risk for melanoma (Lin et al., 2008; Weir et al., 2011). Incidence of melanoma is highest in
Caucasians compared to all other racial groups, regardless of age (SEER, 2011b; Weir et al.,
2011). Melanomas in AYAs suggests that early risk factors play an important role, specifically
the potential for gene-environment interactions due to increased UV exposure from sunlight or
tanning beds/booths and accumulated lifelong UV exposure (Anderson et al., 2009; Weir et al.,
2011).
Definition of Adolescents and Young Adults
The definition of AYAs has developed throughout the years, with many different
definitions existing based on age, psychosocial development, and societal influences
(AYAOPRG, 2006). The Adolescent and Young Adult Oncology Progress Review Group
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(AYAOPRG, 2006) opted to define the AYA population with a wide range in order to be
inclusive of the entire spectrum of cancer patients that continue to experience a lack of
improvement in cancer care and survival (AYAOPRG, 2006). The current definition of AYAs
encompasses individuals diagnosed with cancer from 15 through 39 years of age (AYAOPRG,
2006). Although this age range may be quite wide, individuals in this population are unified
based on their extreme differences in the cancer journey when compared to other age groups
(Wolfson, 2010). Further, prior to this AYA definition, individuals in this age range lacked a
home in cancer care and research, typically being treated on pediatric or adult protocols based on
their cancer diagnosis (AYAOPRG, 2006). The formal definition of AYAs will help streamline
research, interventions, treatment, and awareness efforts in this population (AYAOPRG, 2006).
Tennessee
Tennessee (TN) provides a unique opportunity to investigate AYA cancer in that it is a
state that has distinct geographic and demographic differences. It encompasses major
metropolitan areas, suburban counties, and several rural communities located in the Appalachian
Mountains and the Mississippi Delta region. Tennessee has a predominately Caucasian
population (over 80%) and there are less than 20% African-Americans (Erwin et al., 2010). East
TN has a relatively homogenous Caucasian population, even in major urban areas like Knoxville
(Erwin et al., 2010). Meanwhile, in West TN the percentage of African-Americans is
proportionally higher than the overall state percentage, with figures around 50% (Erwin et al.,
2010). In addition, only 27 of TN’s 95 counties are considered urban, while 68 are rural.
The Tennessee Cancer Registry (TCR) found that TN has the twenty-second highest ageadjusted cancer incidence rate and the fifth highest cancer mortality rate in the nation (Li et al.,
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2010). The TCR Annual Report highlights that the majority of the counties that have high
incidence and mortality rates are located in the Appalachian region of TN (Li et al., 2010). This
finding suggests that Appalachian TN residents may be predisposed to developing cancer due to
certain lifestyle factors (Li et al., 2010). However, to date no research has specifically
investigated melanoma in AYAs to understand the unique characteristics of cancer in this
population in TN. While TN is well known in cancer control and prevention through state of the
art cancer centers like St. Jude’s and Vanderbilt and an established state-wide cancer coalition,
the burden of cancer in AYAs is not fully understood.
This study identifies the characteristics of melanoma in AYAs in TN and examines the
predictors of late stage diagnosis of melanoma in this population. Distinguishing the factors that
contribute to late stage diagnosis and subsequent poor prognosis compared to early stage
diagnosis will help to inform researchers and practitioners when developing melanoma related
interventions with the AYA population. Additionally, understanding the burden of melanoma in
AYAs in TN will help to target this specific population for cancer control and prevention
activities.
Patients and Methods
Data Source
Data were obtained from the Tennessee Cancer Registry (TCR) for all AYA melanoma
cases in TN from 2004-2008. The TCR was established in 1983 and collects comprehensive
information on all TN residents diagnosed with cancer, as well as individuals treated for cancer
in the state (TDOH, 2011). The TCR is part of the National Program of Cancer Registries
(NPCR) that was established in 1992 through the Cancer Registries Amendment Act (CDC,
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2011). The NPCR works to provide cancer surveillance across the nation (CDC, 2011).
Administered by the Centers for Disease Control and Prevention (CDC), state based cancer
registries monitor cancer trends over time; determine patterns of cancer incidence and mortality
in specific populations, and assist in the planning and evaluation of cancer control programs
(CDC, 2011).
The NPCR falls under the jurisdiction of the North American Association of Cancer
Registries (NAACR) for standardization of registry data (Thornton, 2010). Standardization of
cancer registry data is a vital component of cancer surveillance as it provides the basis for having
consistent data across cancer registries in North America (Thornton, 2010). Furthermore, state
registry data must meet NAACR standards of completeness (90% completeness of the data set)
in order to be accepted for NAACR/CDC publication (Hofferkamp, 2008).
The TCR met data completeness standards for the first time in 2004 and have continued
to produce high quality data since then (Li et al., 2010). Data for the current study, years 20042008, met data completeness standards of 95% or higher (Li et al., 2010). The TCR collects data
on cancer incidence, including: the type of cancer, primary site of cancer, stage, first course of
treatment, vital status, and general demographic information (Li et al., 2010). Data are sent to
the TCR from hospitals, pathology labs, physician’s offices, and radiation facilities (Li et al.,
2010). The information on each case is compiled into the database to provide cancer statistics
for the state.
Sample
The sample for this study includes all incident melanoma cancer cases (N=1109) in
AYAs from the Tennessee Cancer Registry for the years 2004-2008, inclusive. AYA cases were
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defined as cancer cases that were diagnosed in individuals of ages 15-39 years, inclusive.
Melanoma cases were classified according to the International Classification of DiseasesOncology (ICD-O-3) site codes C440-C449. Cases with reported stage and insurance status at
melanoma diagnosis (N=327) were used for regression analysis.
Analyses
Analysis of melanoma cases in TN was performed using SAS 9.2 software to understand
predictors of late-stage diagnosis in AYAs. Stage of diagnosis was defined by SEER Summary
Stage and categorized into the following 1) in situ, 2) localized, 3) combined late stage variable
for regional and distant stage. Predictor variables included sex, insurance status, and age group.
Sex was defined as male and female. Insurance status was defined by the NAACR data
dictionary and formatted into not insured, government insurance (Medicare, Medicaid, Tricare,
Veteran’s Affairs, Indian Health Service and Military), and private insurance/ other (insurance
type not specified). Cases with unknown insurance status were excluded from analysis. Age
groups were defined according to five year age intervals as follows: 15-19, 20-24, 25-29, 30-34,
and 35-39. The analysis did not include race due to the lack of adequate differentiation in the
sample. Simple and multiple logistic regression analyses were performed for all predictor
variables. The proportional odds model was used due to the multi-level nature of the dependent
variable, stage at diagnosis. Odds ratios and corresponding confidence intervals were reported.
Descriptive statistics of the overall melanoma sample and those cases with stage at diagnosis
were reported using frequencies, percents, and corresponding chi-squared values.
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Results
A total of 1109 melanoma cases were diagnosed among AYAs in TN from 2004-2008.
Of the 1109 cases reported (Table 2.1): 401 (36.2%) cases were diagnosed in males and 707
(63.8%) cases were diagnosed in females. The majority of the cases were Caucasian (96.5%),
diagnosed with localized stage cancer (69.3%), and were diagnosed between ages 35-39 (37.8%).
Cases with confirmed stage of diagnosis (Table 2.2) were predominately female (65.2%), had
private insurance (90.5%), and were diagnosed between ages 35-39 (36.9%).
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Table 2.1. Characteristics of Melanoma Cases in Tennessee for AYAs, 2004-2008

N=1109
Characteristics

N (%)

Age at diagnosis* (years)
15-19
20-24
25-29
30-34
35-39
Sex*
Female
Male
Race*
Caucasian
Other
Region
Non-Appalachia
Appalachian
Stage*
In Situ
Local
Regional/Distant
Insurance Status*
Not Insured
Government Insurance
Private/Other

42 (3.8)
143 (12.9)
208 (18.7)
297 (26.8)
419 (37.8)
707 (63.8)
401 (36.2)
1039 (96.5)
38 (3.5)
559 (49.6)
550 (50.4)
111 (22.5)
342 (69.4)
40 (8.1)

30 (4.5)
69 (10.5)
560 (85.0)

Year of Diagnosis
2004
2005
2006
2007
2008

*p<0.01
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216 (19.5)
207 (18.7)
239 (21.5)
233 (21.0)
214 (19.3)

Table 2.2. Characteristics of Melanoma in Tennessee for AYAs by Stage at Diagnosis, 2004-2008

N=493
Characteristics
Age at Diagnosis
(years)

Sex*

Insurance
Status*

15-19
20-24
25-29
30-34
35-39

In Situ
N=111
N (%)
3 (2.7)
9 (8.1)
22 (19.8)
28 (25.2)
49 (44.1)

Localized
N=342
N (%)
13 (3.8)
57 (16.7)
71 (20.8)
85 (24.9)
116 (33.9)

Regional/Distant
N=40
N (%)
4 (10.0)
3 (7.5)
4 (10.0)
12 (30.0)
17 (42.5)

Males
Females

27 (24.3)
84 (75.7)

122 (35.8)
219 (64.2)

22 (55.0)
18 (45.0)

Not-Insured
Government
Private/Other

3 (6.8)
1 (2.3)
40 (90.9)

5 (2.0)
10 (4.1)
232 (93.9)

4 (11.1)
8 (22.2)
24 (66.7)

*p<0.01
Proportional odds analysis (Table 2.3) shows the predictors of late stage diagnosis.
Univariate analysis of predictor variables illustrates that government insurance and males are
predictors of late stage diagnosis (p< 0.01). Age (15-19) is moderately significant (p=0.06).
Multivariate analysis shows that government insurance, males, and ages 15-19 are all significant
predictors of late-stage diagnosis (p<0.05).
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Table 2.3. Simple and Multiple Logistic Regression of Melanoma Cases in AYAs in Tennessee:
Predictors of Late Stage Diagnosis
N=327^
Crude
OR a

Adjusted OR
(CI) b

15-19*
20-24
25-29*
30-34

2.64
1.50
1.00
1.23

6.30 (1.74-22.86)
2.16 (0.96-4.83)
0.95 (0.48-1.89)
1.14 (0.57-2.25)

Females vs. Males*

0.48

0.53 (0.30-0.93)

Variable
Age at Diagnosis (years)
(reference: 35-39)

Sex

Insurance Status
(reference: Private/Other)

Not-Insured
2.15
Government Insurance**
6.85
^ Excludes those without known stage at diagnosis or insurance status
a
OR: odds ratio, b CI: 95% confidence interval
*p<0.05, **p<0.01

2.12 (0.54- 8.35)
8.41 (3.04-23.27)

Government insurance served as the greatest predictor of late-stage melanoma diagnosis.
Individuals with government insurance were eight times (OR 8.41, CI 3.04-23.27, p<0.01) more
likely to be diagnosed with late stage melanoma compared to individuals with private or other
types of insurance. Individuals with no insurance were two times (OR 2.12, CI 0.54-8.35, p
0.66) more likely to be diagnosed with late-stage melanoma compared to those with private or
other types of insurance although this finding was not statistically significant. Females were
47% (OR 0.53, CI 0.30-0.93, p=0.03) less likely to be diagnosed with late-stage melanoma
compared to men. Individuals diagnosed with melanoma between ages 15 and 19 were six times
(OR 6.30, CI1.74-22.86, p<0.01) more likely to be diagnosed with late-stage melanoma
compared to individuals in the 35-39 year old age group. Other age groups (20-24, 25-29, and
30-34) were not significant predictors of late-stage diagnosis.
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Interaction between insurance status and age of diagnosis was assessed using an
interaction term in the logistic regression model. Interaction between insurance status and age of
diagnosis was significant (p=0.01) in the final regression model. The age groups that showed
significant (p< 0.05) interaction with insurance status were individuals aged 20-24 who had
government insurance and individuals aged 25-29 who were not insured, suggesting that the joint
effects of these variables combined is different than their individual effects on predicting late
stage diagnosis. The effect of age as a predictor of late stage diagnosis may be influenced by an
individual’s insurance status. Additionally exploration of interaction between age at diagnosis
and insurance status should be explored to fully determine the effects of the independent
variables on late stage melanoma diagnosis.
Discussion
Melanoma is the third most commonly diagnosed cancer in the AYA population in the
United States (Weir et al., 2011). While melanoma is largely preventable, incidence rates
continue to increase in the United States (Weir et al., 2011). Early diagnosis and treatment of
melanoma are vital to prognosis (American Melanoma Foundation, 2006).
The majority of melanoma cases diagnosed in TN were Caucasian females, consistent
with current literature (Bleyer et al., 2006; Weir et al., 2011; Wu et al., 2011). However, this
finding is different compared to older age groups where males are more commonly diagnosed,
suggesting there may be something unique about how melanoma behaves in AYAs (Jemal,
Siegal, Xu, & Ward, 2010). Additionally, males were found to be more likely to be diagnosed
with late stage melanoma; however, females were more likely to be diagnosed with melanoma at
any stage. This finding may illustrate a lack of preventive care and regular melanoma screenings
by AYA males. Unfortunately, many AYAs do not have a primary care physician that can refer
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them to a dermatologist should they notice an abnormal skin lesion (AYAOPRG, 2006; Bleyer,
2007; LSYAA, 2006).
The frequency of melanoma diagnosis increased as age increased and most cases were
diagnosed in the 35-39 year old age bracket. However, AYAs in the 15-19 year old age bracket
were six times more likely to be diagnosed with late-stage melanoma compared to 35-39 year
olds. Melanoma in this age group suggests early life factors are important and may involve a
gene-environment interaction with excessive UV radiation exposure (Anderson et al., 2009; Weir
et al., 2011). Evidence shows an increase in artificial sources of UV exposure through tanning
beds or booths are associated with melanoma (Gallagher, Spinelli, & Lee, 2005; Lazovich et al.,
2010; Robinson, Rigel, & Amonette, 1997). More than 30% of Caucasian, adolescent females
and 11% of Caucasian, adolescent males have reported using a tanning bed or booth in their
lifetime (Demko et al., 2003). The International Agency of Research on Cancer recognizes
tanning beds/booths as a known carcinogen to humans (WHO-IARC, 2004). AYA should be
cautious of excessive UV radiation in a natural or artificial setting.
Insurance status proved to be the greatest predictor of late-stage melanoma diagnosis.
Individuals with government insurance, classified as Medicaid, Military, Veteran’s Affairs,
Indian Health Service, and Tricare, proved to be eight times more likely to be diagnosed with
late-stage melanoma compared to those with no insurance. Those with no insurance did not
significantly differ from private or other insurance. The increased risk of late-stage diagnosis in
those with government insurance may be due to a lack of preventive care in this population, but
additional research must be conducted to determine the implications of insurance status on late
stage diagnosis.
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Finally, interaction between age of diagnosis and insurance status was present in the final
model. The effect of age as a predictor of late stage diagnosis may be influenced by an
individual’s insurance status. Currently, AYAs are the most underinsured of any age group in
the US (Siegal, 2011). Many AYAs do not have consistent, quality health coverage, due to the
uniqueness and transitional period that accompanies this life-stage (Siegal, 2011). Additionally
exploration on interaction between age at diagnosis and insurance status should be investigated
to fully determine the effects of the independent variables on late stage melanoma diagnosis.
Further research should be conducted to understand the significance of insurance status and age
on late-stage diagnosis, specifically looking at the relationship between the two variables.
Strengths and Limitations
This study is the first to provide an overview of the characteristics of AYAs diagnosed
with melanoma in TN from 2004-2008. Additionally, it provides some insight into the predictors
of late-stage diagnosis of melanoma in this age group. The use of the TN Cancer Registry
provided high-quality registry data that met national completion standards.
This study had several limitations. Incomplete reporting served as a major limitation;
with a large percentage of melanoma cases that were either unstaged or missing the SEER
Summary stage variable in the data, ultimately limiting the number of cases included that could
be included in the final analysis. This emphasizes the need for improved primary data reporting
in order to provide a more complete picture of each cancer case. Additionally, characteristics of
unstaged cases should be explored to ensure that there are no significant differences in staged
and unstaged melanoma cases. Case counts for government insurance, no insurance, and the 1519 year old group were small, therefore providing wide confidence intervals. Future research
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with a larger sample size in those categories should be conducted to corroborate the findings of
this study. Additionally, the study only looked at AYA melanoma cases in TN where the sample
was relatively homogenous with regard to race. Finally, combining the cancer registry data with
other population based demographic databases that include information on percent poverty,
education levels, and rural versus urban designations would be helpful to understand more of the
socio-demographic factors associated with late-stage melanoma diagnosis in AYAs.
Public Health Implications
Understanding the melanoma burden in AYAs in TN will help to provide a foundation
for future interventions and prevention and awareness campaigns in the state. Recognizing the
risk factors and predictors of late-stage diagnosis of melanoma in AYAs assists in identifying
which groups to target for public health campaigns. Awareness campaigns about the harmful
effects of UV exposure (both natural and artificial) have proven successful in reducing incidence
rates of melanoma (Weir et al., 2011). This research highlights certain groups in TN to target for
increasing awareness of melanoma. AYAs in the 15-19 year age group and those who rely on
government insurance should be targeted to understand the risks factors for melanoma, to reduce
UV exposure, and to practice regular screenings. This preliminary study provides an initial
description of melanoma in TN and predictors of late-stage diagnosis. However, additional
research needs to be performed to present a more in-depth look at melanoma in AYAs across the
country.
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ABSTRACT
Purpose: Thyroid cancer accounts for roughly 10% of cancers diagnosed in adolescents and
young adults (AYAs) age 15-39 years in the United States. Understanding the types of thyroid
cancer diagnosed in AYAs, and the factors that predict the approach to treatment will aid in
understanding the burden of thyroid cancer in AYAs. Patients and Methods: AYA thyroid
cancer cases were obtained from the Tennessee Cancer Registry for 2004-2008, inclusive.
Thyroid cancer cases and histology were defined according to the International Classification of
Diseases- Oncology (ICD-O-3) site codes. Types of surgery were coded from the SEER
codebook and dichotomized to 1) total thyroidectomy and 2) non- total thyroidectomy.
Histology type, stage at diagnosis, and region (Appalachian vs. non-Appalachian) served as
predictor variables. Results: The majority of thyroid cancers (N=830) occurred in Caucasians
(89.6%), females (79.2%), were diagnosed at a localized stage (77.4%), and were diagnosed
when between ages 35-39 (37.0%). Individuals diagnosed with regional or distant stage thyroid
cancer compared to localized stage were almost three times (OR 2.80, CI 1.34-5.85) more likely
to have a total thyroidectomy. Individuals diagnosed with papillary adenocarcinoma were 3.5
times (OR 3.56, CI1.37-9.19) more likely to have a total thyroidectomy compared to individuals
diagnosed with follicular adenocarcinoma. Conclusion: Stage at diagnosis and specific histology
type were the greatest predictors of total thyroidectomy. Future research studies should use
larger sample sizes to better explore the characteristics of thyroid cancer in AYAs. Specific
cancer prevention and control activities should target AYAs.
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Background
The thyroid gland, located at the front of the lower neck uses iodine to produce several
important metabolic hormones (NCI, 2011b). Thyroid hormones are responsible for controlling
heart rate, body temperature, metabolism, and calcium levels in the blood (NCI, 2011b). The
National Cancer Institute estimates that there will be over 50,000 new cases and almost 2,000
deaths due to thyroid cancer in 2012 (NCI, 2012f). Thyroid cancer is one of the most frequently
diagnosed cancers in adolescents and young adults (AYAs) and accounts for roughly 10% of all
cases in that age group (AYAOPRG, 2006; Bleyer et al., 2005; Wu et al., 2005). In addition,
thyroid cancer is the fifth most commonly diagnosed cancer overall in females (Jemal, Siegal,
Xu, & Ward, 2010).
There are three main histology types of thyroid cancer: differentiated, medullary, and
anaplastic (Tuttle et al., 2010). Differentiated thyroid cancer (including papillary, follicular, and
Hürthle cell) accounts for roughly 95% of all thyroid cancers, medullary for 3% and anaplastic
for 2% (NCI, 2011b; Tuttle et al., 2010). Papillary thyroid cancer is the most commonly
diagnosed histology type in the United States (NCI, 2011b; Tuttle et al., 2010). Known risk
factors for thyroid cancer include: history of having an enlarged thyroid, family history of
thyroid cancer or thyroid disease, specific genetic conditions, exposure to radiation, age 25-65
years, being Asian, and being female (NCI, 2011b; PubMed Health, 2011). Prognosis of thyroid
cancer is dependent on histology type, size of the nodule or tumor, and stage at diagnosis (NCI,
2011b). While thyroid cancers occur more frequently in females who have more thyroid
nodules, death due to thyroid cancer occurs more frequently in males due to diagnosis later in
life (Tuttle et al., 2010).
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Treatment for thyroid cancer typically varies based on age of the patient, size of the
nodule/tumor, histology type, and stage of the cancer (NCI, 2011b). Currently, no prospective
randomized treatment trials have been performed to determine the best treatment approach for
thyroid cancer (Tuttle et al., 2010). The most common type of treatment for thyroid cancer is
surgery (NCI, 2011b). The extent of thyroid surgery can range from a lobectomy to a full
thyroidectomy (NCI, 2011b; Tuttle et al., 2010). Total thyroidectomy can be used for all types of
thyroid cancer and involves removal of the entire thyroid gland. The thyroidectomy is usually
followed by radioactive iodine therapy to kill any remaining cancer cells (NCI, 2011b). The
other main surgery type is a lobectomy, where a lobe of the thyroid and the isthmus are removed
(NCI, 2011b). Some individuals that initially have a lobectomy will later have a total
thyroidectomy due to cancer recurrence and/or complications.
Based on the type of initial treatment, about 30% of patients diagnosed with
differentiated thyroid cancer have tumor recurrences. Patients younger than 20 years of age have
some of the highest recurrence frequencies (40%) (Mazzaferri & Jhiang, 1994; Sherman et al.,
1998). This may be due to the fact that most physicians feel as though the prognosis of thyroid
cancer in young people is favorable and therefore the cancer is classified as a low-risk tumor and
treated with less invasive surgery (Samuel, Rajashekharrao, & Shah, 1998; Tuttle et al., 2010).
Most patients can be cured of thyroid cancer with proper treatment; however, following surgery,
thyroid hormone replacement will be necessary for the remainder of their lives (NCI, 2011b;
Sherman, 2003). Understanding the types of thyroid cancer diagnosed in AYAs, the extent of
the surgery performed, and factors that predict surgery outcomes will help aid in understanding
the burden of thyroid cancer in AYAs.
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Definition of Adolescents and Young Adults
The definition of AYAs has developed throughout the years, with many different
definitions existing based on age, psychosocial development, and societal influences
(AYAOPRG, 2006). The Adolescent and Young Adult Oncology Progress Review Group
(AYAOPRG, 2006) opted to define the AYA population with a wide range in order to be
inclusive of the entire spectrum of cancer patients that continue to experience a lack of
improvement in cancer care and survival (AYAOPRG, 2006). The current definition of AYAs
encompasses individuals diagnosed with cancer from 15 to 39 years of age (AYAOPRG, 2006).
Although this age range may be quite wide, individuals in this population are unified based on
their extreme differences in the cancer journey when compared to other age groups (Wolfson,
2010). Further, prior to this AYA definition, individuals in this age range lacked a home in
cancer care and research, typically being treated on pediatric or adult protocols based on their
cancer diagnosis (AYAOPRG, 2006). The formal definition of AYAs will help streamline
research, interventions, treatment, and awareness efforts in this population (AYAOPRG, 2006).
Tennessee
Tennessee (TN) provides a unique opportunity to investigate thyroid cancers in AYAs
because it has distinct geographic and demographic differences. It encompasses metropolitan
areas and rural communities located in the Appalachian Mountains and the Mississippi Delta
region. Only 27 of TN’s 95 counties are considered urban, while 68 are rural (Erwin et al.,
2010). Over 80% of Tennessee residents are Caucasian; with less than 20% African-Americans
(Erwin et al., 2010). East TN has a relatively homogenous Caucasian population, even in major
urban areas like Knoxville (Erwin et al., 2010). Meanwhile, in West TN the percentage of
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African-Americans is proportionally higher than the overall state percentage, with figures around
50% (Erwin et al., 2010).
There has not been any prior reported research dealing with thyroid cancers in AYAs in
TN. TN is well known in cancer control and prevention through state of the art cancer centers
like St. Jude’s and Vanderbilt and an established state-wide cancer coalition, however, the
burden of cancer in AYAs is not fully understood.
Patients and Methods
Data Source
Data were obtained from the TCR for all AYA thyroid cancer cases in TN from 20042008. Established in 1983, the TCR collects comprehensive information on all TN residents
diagnosed with cancer, as well as individuals treated for cancer in the state (TDOH, 2011). The
TCR is part of the National Program of Cancer Registries (NPCR) (CDC, 2012). Administered
by the Centers for Disease Control and Prevention (CDC), state based cancer registries monitor
cancer trends over time; determine patterns of cancer incidence and mortality in specific
populations, and assist in the planning and evaluation of cancer control programs.
The NPCR falls under the jurisdiction of the North American Association of Cancer
Registries (NAACR) for standardization of registry data (Thornton, 2010). Standardization of
cancer registry data is a vital component of cancer surveillance as it provides the basis for having
consistent data across cancer registries in North America (Thornton, 2010). State registry data
must meet NAACR standards of completeness (90% completeness of the data set) in order to be
accepted for NAACR/CDC publication (Hofferkamp, 2008).
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The TCR met data completeness standards for the first time in 2004 and have continued
to produce high quality data since then (Li et al., 2010). Data for the current study, years 20042008, met data completeness standards of 95% or higher (Li et al., 2010). The TCR collects data
on cancer incidence, including: the type of cancer, primary site of cancer, stage, first course of
treatment, vital status, and general demographic information (Li et al., 2010). Data are sent to
the TCR from hospitals, pathology labs, physician’s offices, and radiation facilities (Li et al.,
2010). The information on each case is compiled into the database to provide cancer statistics
for the state.
Sample
The sample for this study includes all incident thyroid cancer cases (N=830) in AYAs
from the Tennessee Cancer Registry for the years 2004-2008, inclusive. AYA cases were
defined as cancer cases that were diagnosed in individuals ages 15-39 years, inclusive. Thyroid
cancer cases and their histology were defined according to the International Classification of
Diseases- Oncology (ICD-O-3) site code, C739. General demographic and descriptive
information included gender, age, insurance status, county of diagnosis, marital status, and race.
Cancer specific information such as primary cancer site, stage at diagnosis, treatment type, and
vital status are also reported for each case.
Analyses
Analysis was performed using SAS 9.2 software (SAS Institute, 2009). Thyroid cancer
cases of AYAs in TN were analyzed to understand predictors of a total thyroidectomy used as a
surgery treatment option. Surgery of the primary site codes were provided by the NAACR data
dictionary and the SEER Program code manual for thyroid cancer specific surgery procedures.
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Surgery was dichotomized into total thyroidectomy versus other, less invasive surgical
procedures. Individuals that did not receive surgery as a treatment outcome (N=6) were
excluded from analysis in order to minimize bias in the sample. The following predictors were
included in the final model: histology type, stage at diagnosis, and region. Stage at diagnosis
was coded into localized and a combined regional and distant stage due to low counts in the last
two categories. Region was coded into Appalachian and Non-Appalachian by county of
diagnosis codes. Sex, race, and 5-year age groups were evaluated but were not included in the
final model as they were not significant predictors of a thyroidectomy in either univariate or
multivariate analysis. Univariate and multivariate analysis were performed for the predictor
variables. Odds ratios and corresponding confidence intervals were reported. Descriptive
statistics of the overall thyroid cancer sample and those cases included in the final model were
reported using frequencies, percents, and corresponding chi-squared values.
Results
A total of 830 thyroid cancer cases were diagnosed among AYAs in TN from 2004-2008.
Of the 830 cases reported (Table 3.1): 173 (20.8%) cases were in males and 657(79.2%) were in
females. Most cases were Caucasian (89.6%) and were diagnosed with localized stage cancer
(77.4%). Thyroid cancer occurred most commonly between the ages 35-39 (37.0%). The most
common histology type of thyroid cancer diagnosed was papillary adenocarcinoma, 320 cases
(38.6%). Cases that received a total thyroidectomy as a treatment outcome (Table 3.2) were
predominately female (77.6%), were diagnosed with localized stage thyroid cancer (72.8%), and
were diagnosed with papillary adenocarcinoma (42.2%).
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Table 3.1. Characteristics of Thyroid Cancer Cases in Tennessee for AYAs, 2004-2008
N=830
Characteristics

N (%)

Age at diagnosis* (years)
15-19
20-24
25-29
30-34
35-39

23 (2.8)
88 (10.6)
160 (19.3)
252 (30.3)
307 (37.0)

Female
Male

657 (79.2)
173 (20.8)

Caucasian
Other

741 (89.6)
86 (10.4)

Appalachian
Non-Appalachian

363 (43.7)
467 (56.3)

Localized
Regional/Distant

270 (77.4)
79 (22.6)

Sex*

Race*

Region*

Stage*

Year of Diagnosis**
2004
2005
2006
2007
2008

140 (16.9)
145 (17.5)
181 (21.8)
184 (22.2)
180 (21.7)

Histology Type*
Follicular Adenocarcinoma
Papillary Adenocarcinoma
Papillary Carcinoma
Papillary & Follicular Carcinoma
Other

49 (5.9)
320 (38.6)
171 (20.6)
248 (29.9)
42 (5.1)

*p<0.01 **p<0.05
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Table 3.2. Characteristics of Thyroid Cancer in Tennessee for AYAs by Surgery Type,
2004-2008

N=824
Characteristics

Total Thyroidectomy
N=618
N (%)

Other
N=206
N (%)

Follicular Adenocarcinoma
Papillary Adenocarcinoma
Papillary Carcinoma
Papillary & Follicular
Carcinoma
Other

25 (4.1)
261 (42.2)
118 (19.1)

24 (11.7)
57 (16.7)
71 (20.8)

183 (29.6)
31 (5.0)

85 (24.9)
116 (33.9)

Sex

Females
Males

480 (77.7)
138 (22.3)

173 (83.5)
34 (16.5)

Stage*

Localized
Regional/Distant

182 (72.8)
68 (27.2)

88 (89.8)
10 (10.2)

Histology Type*

*p<0.01
Logistic regression analyses (Table 3.3) were performed to determine the predictors of a
having a total thyroidectomy for treatment. Simple logistic regression analysis illustrates that
localized stage at diagnosis, non-Appalachian region, and papillary adenocarcinoma histology
type are predictors of total thyroidectomy procedure (p< 0.01). Multiple logistic regression
analysis shows that stage at diagnosis and non-Appalachian region are the strongest predictors of
total thyroidectomy. Papillary adenocarcinoma and papillary carcinoma compared to follicular
adenocarcinoma are associated with an increased risk of a total thyroidectomy.
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Table 3.3. Predictors of Total Thyroidectomy in AYAs in Tennessee:
Simple and Multiple Logistic Regression
N=348^
Crude
OR a

Adjusted OR
(CI) b

Papillary Adenocarcinoma
Papillary Carcinoma
Papillary & Follicular Carcinoma
Other

4.40
2.27
2.70
2.98

3.56 (1.37-9.19)*
2.64 (1.02-6.83)**
2.10 (0.84-5.28)
3.68 (0.78-17.4)

Non-Appalachian

1.37

2.07 (1.26-3.42)*

Regional/Distant

3.29

2.80 (1.34- 5.85)*

Variable
Histology Type
(reference: Follicular
Adenocarcinoma)

Region
(reference: Appalachian)

Stage
(reference: Localized)

^Includes cases that had known stage at diagnosis and histology type
a
OR: odds ratio, b CI: 95% confidence interval
*p<0.01, ** p<0.05
Histology type is a major and significant predictor of total thyroidectomy. Individuals
diagnosed with papillary adenocarcinoma were 3.5 times (OR 3.56, CI1.37-9.19, p<0.01) more
likely to have a total thyroidectomy while those with papillary carcinoma were two times (OR
2.64, CI 1.02-6.83, p<0.05) more likely to have a total thyroidectomy compared to individuals
diagnosed with follicular adenocarcinoma. Other histology types did not significantly predict
total thyroidectomy as compared to follicular adenocarcinoma. Stage also served as a predictor
of a total thyroidectomy procedure. Individuals diagnosed with regional or distant stage thyroid
cancer were almost three times (OR 2.80, CI 1.34-5.85, p<0.01) more likely to have a total
thyroidectomy compared with those diagnosed with localized stage thyroid cancer. Individuals
living in the non-Appalachian region of TN were two times (OR 2.07, CI 1.26-3.42, p<0.01)
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more likely to have a total thyroidectomy performed compared to those living in the Appalachian
region of TN.
Discussion
Thyroid cancer accounts for more than 10% of all cancers in the AYA population and
disproportionately affects females (AYAOPRG, 2006; Bleyer, 2005; Wu et al., 2005).

Thyroid

nodules, typically benign lumps found in the thyroid, are roughly four times more common in
women than men and thyroid cancer is two to three times more common in women than men
(Tuttle et al., 2010). The current study represents the first to evaluate thyroid cancer in AYAs in
TN and to determine the predictors of total thyroidectomy. Almost 80% of thyroid cancers in
TN AYAs were diagnosed in females, consistent with current literature (AYAOPRG, 2006;
Bleyer, 2005; Tuttle et al., 2010; Waguespack, Wells, Ross, & Bleyer, 2006; Wu el al., 2005).
About 90% of the cases were in Caucasians, which is also consistent with the current literature
(Tuttle et al., 2010; Waguespack et al., 2006). Asian/Pacific Islanders are at a greater risk for
developing thyroid cancer (NCI, 2011b; Waguespack et al., 2006); however, the small sample
size of this race in the current study did not allow for evaluation of this variable for TN.
The results of this study reveal several important observations. Differentiated thyroid
cancer types accounted for 95% of the thyroid cancers in AYAs in TN. The majority of
differentiated thyroid cancers (89.1%) were some type of papillary carcinoma (papillary
carcinoma, papillary adenocarcinoma, and papillary and follicular carcinoma). These findings
are consistent with the existing literature (NCI, 2011b; Tuttle et al., 2010; Waguespack et al.,
2006).
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Specific histology types were found to be a significant predictor of total thyroidectomy.
Papillary adenocarcinoma was the strongest significant predictor and was three times more likely
to be associated with total thyroidectomy as compared to follicular adenocarcinoma. Papillary
carcinoma and papillary adenocarcinoma were the only histology types that significantly
predicted total thyroidectomy as a surgical outcome. Interestingly, follicular tumors are
considered to be more aggressive than papillary tumors (Tuttle et al., 2010) and it might be
assumed they would be treated by more a more aggressive surgical procedure. However, the
number of follicular adenocarcinomas in the sample were small. Additional research to identify
the reasons for surgical choice as based on histology type would be beneficial. Additionally,
understanding the type of surgeon and the experience level of the surgeon would assist in
predicting future complications (Tuttle et al., 2010).
Tumor stage at diagnosis was a major predictor of total thyroidectomy. While the
majority of the sample were diagnosed with localized stage cancer, those diagnosed with
regional or distant stage cancer were two times more likely to have a total thyroidectomy.
Unfortunately, due to the slow growth and lack of obvious symptoms of differentiated thyroid
cancers, there are often long delays in diagnosis that could result in a later stage cancer at
diagnosis and substantial worse outcomes (Mazzaferri & Jhiang, 1994; Tuttle et al., 2010).
Because delays in diagnosis generally exist in the AYA population, awareness of thyroid cancer
symptoms should be increased for AYAs and medical practitioners who see this age group.
Individuals living in the non-Appalachian region of TN were two times more likely to
undergo a total thyroidectomy compared to those living in the Appalachian region. There was a
slightly higher frequency in the number of thyroid cancer cases diagnosed in the nonAppalachian region versus the Appalachian region (467 cases vs. 363 cases). The increased
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probability of a total thyroidectomy procedure in the non-Appalachian region could signify
several things. First, individuals diagnosed in non-Appalachian regions of TN may have more
access to specialized surgeons and oncologists who would use a more aggressive treatment plan.
Another explanation might be that individuals in non-Appalachian regions may present with later
stage cancers or different histology types that would more likely to be treated with a total
thyroidectomy. Further research should be conducted to understand the difference between
thyroid cancer treatment and outcomes in the Appalachian and non-Appalachian regions of TN.
Strengths and Limitations
The use of the TN Cancer Registry provided high-quality data that met national standards
of the North American Association of Cancer Registries. The study served as a preliminary
study to gain more information on the specific characteristics of thyroid cancer in the AYA
population in TN. This is the first study to use the TN Cancer Registry to look at the distinct
features of thyroid cancer in AYAs and those factors that predict total thyroidectomy in this
population.
There are some limitations in this study. Lack of racial heterogeneity does not allow
these findings to be generalized to populations with more racial and ethnic diversity. Incomplete
reporting of stage at diagnosis was also a limitation and many cases were either unstaged or
unreported. This research was conducted using only TN data and can provide information on
AYA thyroid cancer cases only for TN. Future research that includes additional sociodemographic variables that may provide insight into access to qualified medical practitioners and
cancer facilities would help to further inform predictors of a patient receiving a total
thyroidectomy as a surgical treatment option.
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Public Health Implications
Investigating cancer in the AYA population is important to understanding the overall
cancer burden in TN. AYAs are currently an understudied population and this study provides the
first step into identifying the characteristics of thyroid cancer in AYAs. Thyroid cancer is one of
the most commonly diagnosed cancers in AYAs, specifically in females. Female AYAs in TN
and general medical practitioners that serve this population should be targeted to increase
awareness of thyroid cancer signs and symptoms and screenings. Finally, researchers need to
take the additional steps to understand and decrease disparities in thyroid cancer morbidity based
on region and type of surgery received.
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CHAPTER 5
DISCUSSION AND CONCLUSION
The recent expanded definition of the AYA age group to cover 15 to 39 years by the
Adolescent and Young Adult Oncology Peer Review Group and the National Cancer Institute
(2006) has provided a basis for an increased focus on cancer research in this age group. This
expanded definition provides an opportunity to study an under-served, under-represented
population in cancer research. The types of cancers affecting AYAs and the associated risk
factors are not fully understood. In addition, there are distinct psychosocial and survival issues
that impact this age group and that deserve further exploration and study.

Use of state cancer registries to provide an in-depth picture of AYA cancer at the statelevel is the first step in understanding the cancer burden for this population as the state level.
Identifying cancers that specifically affect AYAs will help to target cancer prevention and
control activities for this group. Prior to this study, very few AYA cancer research projects have
focused on a specific state; instead most have used national data. Prior research on cancer in
AYAs has not focused solely on TN. The current research study explored the characteristics of
AYAs with cancer in TN and provides a foundation for future research in this field. Focusing
specifically on TN provided the opportunity for an in-depth look at AYA cancers as a basis of
better understanding the cancer burden at the state level. In order to effectively target public
health prevention and awareness for AYAs, health practitioners need data regarding the cancer
burden based in their state in order to know which groups to target for those efforts. This profile
of AYA cancers in TN will help to develop and implement prevention and awareness efforts for
the state.
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Several key findings resulted from this research study. The knowledge that breast cancer,
melanoma, lymphomas, thyroid cancer, and testicular cancer are the most frequently diagnosed
cancers in AYAs in TN should help to develop age-specific awareness and screening campaigns
based on cancer type. Knowledge of the increased incidence rates for breast cancer and
melanoma in AYA females in TN provides a basis for developing age-specific prevention and
interventions based on the risk factors for those cancers. In addition, knowing that there are
disparities in late-stage melanoma diagnosis based on age and insurance status will help
practitioners focus on those groups to promote early detection. Finally, distinguishing the
histology types and other predictors of a having a total thyroidectomy as a surgery treatment
option should help understand the reasons for the type of treatment that AYAs receive.

Additional future research concentrated on the AYA population will help to provide a
greater evidence base for this field. Understanding the AYA cancer experience will assist in
eliminating disparities in cancer care and research in this age group. Future research that links
the TN Cancer Registry data base with socio-demographic characteristics such as poverty levels,
educational attainment, and rural- urban designations will assist in providing a greater
understanding of socio-demographic risk factors for AYA cancer. Insurance status and type of
insurance should also be investigated to determine if AYAs are being marginalized due to a lack
of consistent and sufficient insurance. Also, comprehending where AYAs in TN are being
treated and by what types of practitioners will offer insight into the AYA cancer journey.
Finally, research on the AYA cancer burden in TN will help to inspire public health interventions
and campaigns emphasized on AYAs.
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